GREGOIRE, C., DETRY, O., Jouret, F., BRIQUET, A., LECHANTEUR, C., BAUDOUX, E., Beguin, Y., & GIET, O. (2017). The use of mesenchymal stromal cells in solid organ transplantation. In The Biology and Therapeutic Application of Mesenchymal Cells (pp. 825-835). Hoboken, United States: John Willey & Sons, Inc. |
GREGOIRE, C., Louis, E., BRIQUET, A., LECHANTEUR, C., BAUDOUX, E., GIET, O., Beguin, Y., & BARON, F. (2017). The role of mesenchymal stromal cells in the treatment of ulcerative colitis and Crohn’s disease. In The Biology and Therapeutic Application of Mesenchymal Cells (pp. 730-753). Hoboken, United States: John Wiley & Sons, Inc. |
Beguin, Y. (2008). Erythropoiesis. In C. Gasche, Anemia in inflammatory bowel disease (pp. 38-42). Uni-Med Verlag. |
Beguin, Y., & Estatiev, R. (2008). Iron deficiency. In C. Gasche, Anemia in inflammatory bowel disease (pp. 42-47). Uni-Med Verlag. |
Beguin, Y., & Vanstraelen, G. (2008). Prediction of response to recombinant human erythropoietin in the anemia of cancer. In M. R. Nowrousian, Recombinant human erythropoietin (rhEPO) in clinical oncology (2nd Ed.). Berlin - Heidelberg, Germany: Springer-Verlag. |
Vanstraelen, G., & Beguin, Y. (2008). rhEPO in hematopoietic stem cell transplantation. In M. R. Nowrousian, Recombinant human erythropoietin (rhEPO) in clinical oncology (2nd Ed.) (pp. 583-614). Berlin - Heidelberg, Germany: Springer-Verla. |
Beguin, Y., Dujardin, C., Piron, M., & Vanstraelen, G. (2006). Treatment of anaemia with erythropoietin. In C. Brugnara & C. Beaumont, ESH Scientific Updates. Disorders of Iron Homeostasis, Erythrocytes and erythropoiesis (pp. 180-209). Elsevier Science. |
Beguin, Y. (2005). Erythropoietic agents and iron. In M. Aapro, C. Bokemeyer, ... H. Ludwig, ESO Scientific Updates, Vol. 6 (2nd ed). Anaemia in cancer (pp. 199-220). Elsevier Science. |
Beguin, Y. (2005). Endogenous erythropoietin in the anemia of chronic disorders. In W. Weiss, V. R. Gordeuk, ... C. Hershko, Anemia of chronic disease (pp. 145-200). New York, United States - New York: Marcel Dekker. |
Beguin, Y. (2002). Predictive factors for response of anemia to recombinant human erythropoietin. In M. R. Nowrousian, Recombinant human erythropoietin (rhEPO) in clinical oncology (pp. 263-286). Berlin - Heidelberg, Germany: Springer-Verlag. |
Beguin, Y. (2001). Prediction of response to rHuEpo. In C. Bokemeyer & H. Ludwig, ESO Scientific Upadtes, Vol. 6 Anaemia in cancer (pp. 153-165). Elsevier Science. |
Clement, J., De Bock, R., & Beguin, Y. (1994). Defective Epo production contributes to anemia persistent after ARF in nephropathia epidemica (NE). In Papadimitriou & Alexopoulos, Proceedings of the 3rd International Satellite Symposium on Acute Renal Failure (pp. 467-473). Thessaloniki, Greece: University Studio Press. |
Baudoux, E., Janssens, M., Beguin, Y., Sondag, D., Fillet, G., & Lamy, M. (1993). Erythropoietin in surgery. In Proceedings of the 4th Regional Congress of the International Society of Blood Transfusion (pp. 213-217). |
Fillet, G., & Beguin, Y. (1992). Iron availability for erythropoiesis. In C. Drewienkiewicz, The potential use of erythropoietin to diminish the need for homologous blood in surgery (pp. 43-49). Medical Action Communication. |
Beguin, Y., Huebers, H., Finch, C. A., Weber, G., & Roelandts, I. (1988). The regulation of liver iron metabolism. In P. Bratter & P. Schramel, Trace element analytical chemistry in medicine and biology, Vol. 5 (pp. 542-547). Walter de Gruyter. |
Beguin, Y., Weber, G., Delbrouck, J.-M., Robaye, G., Roelandts, I., Bury, J., & Fillet, G. (1987). Dosage du zinc sérique chez des patients atteints de leucémie aiguë. In A. Favier, J. Arnaud, ... H. Faure, Le zinc en médecine et biologie (pp. 224-226). Paris, France: Editions Médicales Internationales. |
Beguin, Y., Detroz, B., Defraigne, J.-O., Bury, J., Boniver, J., Fillet, G., & Lejeune, G. (1985). Solitary plasmacytoma of the thyroid with serum monoclonal IgG. In J. Radl, W. Hijmans, ... B. Van Camp, Monoclonal gammopathies. Clinical significance and basic mechanisms (pp. 251-253). Eurage. |
Beguin, Y., Delbrouck, J.-M., Roelandts, I., & Weber, G. (1984). Serum trace elements in hemoproliferative diseases. In P. Bratter & P. Schramel, Trace element analytical chemistry in medicine and biology, Vol. 3 (pp. 383-389). Walter de Gruyter. |
Lombardo, G., HAFRAOUI, K., Beguin, Y., & VERTENOEIL, G. (February 2024). Comment j’explore … une polyglobulie. Revue Médicale de Liège, 79 (2), 110 - 115. |
Conrad, A., Beguin, Y., Guenounou, S., Le Bourgeois, A., Ménard, A.-L., Rialland, F., Layal, S., Mamez, A.-C., Yakoub-Agha, I., & El Cheikh, J. (2024). Mise à jour du calendrier vaccinal après allogreffe de cellules souches hématopoïétiques : recommandations de la Société francophone de greffe de moelle et de thérapie cellulaire (SFGM-TC). Bulletin du Cancer, 111 (25), 40-S49. doi:10.1016/j.bulcan.2023.05.007 |
Lacan, C., Lambert, J., Forcade, E., Robin, M., Chevallier, P., Loron, S., Bulabois, C.-É., Orvain, C., Ceballos, P., Daguindau, E., Charbonnier, A., Chalandon, Y., Bernard, M., Simand, C., Rubio, M.-T., Turlure, P., Maertens, J., Huynh, A., Loschi, M., ... Nguyen, S. (2024). Bone marrow graft versus peripheral blood graft in haploidentical hematopoietic stem cells transplantation: a retrospective analysis in1344 patients of SFGM-TC registry. Journal of Hematology and Oncology, 17, 2. doi:10.1186/s13045-023-01515-4 |
Ortí, G., Gras, L., Koster, L., Kulagin, A., Byrne, J., Apperley, J. F., Halaburda, K., Blau, I. W., Clark, A., Kröger, N., Griskevicius, L., Carlson, K., Collin, M., Bloor, A., Raiola, A. M., Blaise, D., Aljurf, M., López-Corral, L., Sakellari, I., ... Yakoub-Agha, I. (2024). Graft-versus-Host Disease Prophylaxis with Post- Transplantation Cyclophosphamide in Chronic Myeloid Leukemia Patients Undergoing Allogeneic Hematopoietic Cell Transplantation from an Unrelated or Mismatched Related Donor: A Comparative Study from the Chronic Malignancies Working Party of the EBMT (CMWP-EBMT). Transplantation and Cellular Therapy, 30, 93.e1 - 93.e12. doi:10.1016/j.jtct.2023.09.019 |
Robin, M., Gras, L., Koster, L., Gagelmann, N., van Gorkom, G., Ederr, M., Itälä-Remes, M., Zuckerman, T., Beguin, Y., Schaap, N., Drozd-Sokolowska, J., Raj, K., Hayden, P. J., de Wreede, L. C., Battipaglia, G., Polverelli, N., Czerw, T., Hernandez Boluda, J. C., Kröger, N., ... McLornan, D. P. (2024). Early liver complications after allogeneic haematopoietic stem cell transplantation in patients with myelofibrosis: A study on behalf of the Chronic Malignancies Working Party of the EBMT. British Journal of Haematology, 204, 715 - 718. doi:10.1111/bjh.19214 |
Voisot, A., Triffaux, F., Roland, I., Meex, C., Detrembleur, N., Baron, F., WILLEMS, E., WALTREGNY, D., Beguin, Y., & Servais, S. (22 September 2023). Endovesical instillation of Cidofovir in the treatment of BK polyomavirus hemorrhagic cystitis after allogeneic hematopoietic cell transplantation. Current Research in Translational Medicine, 71 (1), 103366. doi:10.1016/j.retram.2022.103366 |
COVID-19 Host Genetics Initiative, Rahmouni, S., Georges, M., Moutschen, M., Darcis, G., & Beguin, Y. (September 2023). A second update on mapping the human genetic architecture of COVID-19. Nature, 621 (7977), 7 - E26. doi:10.1038/s41586-023-06355-3 |
Ritacco, C., Köse, M. C., Courtois, J., Canti, L., Beguin, C., DUBOIS, S., Vandenhove, B., Servais, S., Caers, J., Beguin, Y., Ehx, G.* , & Baron, F.*. (17 March 2023). Post-transplant cyclophosphamide prevents xenogeneic graft-versus-host disease while depleting proliferating regulatory T cells. iScience, 26 (3), 106085. doi:10.1016/j.isci.2023.106085 * These authors have contributed equally to this work. |
Erpicum, P., Pinto Coelho, T., BONVOISIN, C., Bouquegneau, A., GROSCH, S., Navez, M., Vandermeulen, M., Beguin, Y., Detry, O., Jouret, F., & WEEKERS, L. (February 2023). Reprise retardée de fonction du greffon après transplantation rénale : un challenge clinique toujours d’actualité. Revue Médicale de Liège, 78 (2), 107 - 113. |
Bayoudh, F., Giot, J.-B., Descy, J., Fontaine, C., Hayette, M.-P., Baron, F., WILLEMS, E., Beguin, Y., FRIPPIAT, F., & Servais, S. (2023). Oral minocycline as systemic therapy for uncomplicated venous access device-related bloodstream infection with coagulase-negative staphylococci after allogeneic hematopoietic cell transplantation. Current Research in Translational Medicine, 72 (1), 103422. doi:10.1016/j.retram.2023.103422 |
Chauvet, P., Paviglianiti, A., Labopin, M., Labussière, H., Boissel, N., Robin, M., Maillard, N., Ouachée-Chardin, M., Forcade, E., Poiré, X., Chantepie, S., Huynh, A., Bulabois, C., Leclerc, M., Maury, S., Chevallier, P., Cluzeau, T., Mear, J., Cornillon, J., ... Brissot, E. (2023). Combining blinatumomab and donor lymphocyte infusion in B-ALL patients relapsing after allogeneic hematopoietic cell transplantation: A study of the SFGM-TC. Bone Marrow Transplantation, 58, 72-79. doi:10.1038/s41409-022-01846-9 |
El Moussaoui, M., Desmecht, S., Lambert, N., Maes, N., Braghini, J., MARECHAL, N., Quintana, C., BRIQUET, K., Gofflot, S., Toussaint, F., Hayette, M.-P., Vermeersch, P., Lutteri, L., GREGOIRE, C., Beguin, Y., Rahmouni, S., Moutschen, M., Desmecht, D., & Darcis, G. (2023). Cluster Analysis Identifies Distinct Patterns of T-Cell and Humoral Immune Responses Evolution Following a Third Dose of SARS-CoV-2 Vaccine in People Living with HIV. Viruses, 15, 1435. doi:10.3390/v15071435 |
Kaphan, E., Bettega, F., Forcade, E., Labussière-Wallet, H., Fegueux, N., Robin, M., Peffault De Latour, R., Huynh, A., Lapierre, L., Berceanu, A., Marcais, A., Debureaux, P.-E., Vanlangendonck, N., Bulabois, C.-E., Magro, L., Daniel, A., Galtier, J., Lioure, B., Chevallier, P., ... Thiebaut-Bertrand, A. (2023). Late relapse after hematopoietic stem cell transplantation for acute leukemia: a retrospective study by SFGM-TC. Transplantation and Cellular Therapy, 362, 1 - e12. doi:10.1016/j.jtct.2023.02.020 |
Lejeune, M., Köse, M. C., Jassin, M., Gou, M.-J., Herbet, A., Duray, E., Cobraiville, G., FOGUENNE, J., Boquet, D., Gothot, A., Beguin, Y., Fillet, M., & Caers, J. (2023). Integrative Analysis of Proteomics and Transcriptomics Reveals Endothelin Receptor B as Novel Single Target and Identifies New Combinatorial Targets for Multiple Myeloma. HemaSphere, 22, 901. doi:10.1097/HS9.0000000000000901 |
Michel, C., Robin, M., Morisset, S., Blaise, D., Maertens, J., Chevalier, P., Castilla-Llorente, C., Forcade, E., Ceballos, P., Yakoug-Agha, I., Poire, X., Carre, M., Bay, J.-O., Beguin, Y., Loschi, M., Huynh, A., Guillerm, G., François, S., Mear, J.-B., ... D'Aveni, M. (2023). Outcome after allogeneic stem cell transplantation with haploidentical versus HLA-matched donors in patients with higher-risk MDS. Bone Marrow Transplantation, 58, 534 - 543. doi:10.1038/s41409-023-01931-7 |
Reenaers, C., GILLARD, R., Coimbra, C., GILLARD, R., Meunier, P., LECHANTEUR, C., BAUDOUX, E., BOUTAFFALA, L., Beguin, Y., & Louis, E. (2023). Clinical and MRI evolution after local injection of bone marrow-derived mesenchymal stem cells in perianal fistulae in Crohn’s disease: results from a prospective monocentric study. Journal of Crohn's and Colitis, 17, 728-737. doi:10.1093/ecco-jcc/jjac192 |
Rey, G., Daguenet, E., Bonjean, P., Devillier, R., Fegueux, N., Forcade, E., Srour, M., Chevallier, P., Robin, M., Suarez, F., Micol, J.-B., Labussière-Wallet, H., Bilger, K., Daguindau, E., Bay, J.-O., Fayard, A., Bulabois, C.-E., Nguyen-Quoc, S., Genthon, A., ... Tavernier, E. (2023). Allogeneic hematopoietic stem cell transplantation for adults with therapy-related acute myeloid leukaemia: a retrospective multicentre study on behalf of the SFGM-TC. Bone Marrow Transplantation, 58, 1331 - 1338. doi:10.1038/s41409-023-02082-5 |
Saccardi, R., Putter, H., Eikema, D., Busto, M., McGrath, E., Middelkoop, B., Adams, G., Atlija, M., Ayuk, A., Baldomero, H., Beguin, Y., del la Camara, R., Cedillo, A., Sureda, A., Chabannon, C., Corbacioglu, S., Dolstra, H., Duarte, R., Dulery, R., ... Snowden, J. (2023). Benchmarking of survival outcomes following Haematopoietic Stem Cell Transplantation (HSCT): an update of the ongoing project of the European Society for Blood and Marrow Transplantation (EBMT) and Joint Accreditation Committee of ISCT and EBMT (JACIE). Bone Marrow Transplantation, 58, 659-666. doi:10.1038/s41409-023-01924-6 |
Schmitz, L., Pirotte, M., Lebeau, A., Ernst, M., Fillet, M., DEVEY, A., SCHMITT, J., Cobraiville, G., BINSFELD, M., Gofflot, S., Beguin, Y.* , & Vertenoeil, G.*. (2023). Alterations of erythropoiesis in Covid-19 patients: prevalence of positive Coombs tests and iron metabolism. Therapeutic Advances in Hematology, 14, 20406207231199837. doi:10.1177/20406207231199837 * These authors have contributed equally to this work. |
Servais, S., Baron, F., LECHANTEUR, C., Seidel, L., BAUDOUX, E., BRIQUET, A., Selleslag, D., Maertens, J., Poire, X., Schroyens, W., Graux, C., De Becker, A., Zachee, P., Ory, A., Herman, J., Kerre, T., & Beguin, Y. (2023). Multipotent mesenchymal stromal cells as treatment for poor graft function after allogeneic hematopoietic cell transplantation: A multicenter prospective analysis. Frontiers in Immunology, 14. doi:10.3389/fimmu.2023.1106464 |
Srour, M., Alsuliman, T., Labreuche, J., Bulabois, C., Chevalier, P., Daguindau, E., Forcade, E., François, S., Guillerm, G., Coiteux, V., Turlure, P., Beguin, Y., Yakoub-Agha, I., & Magro, L. (2023). Nilotinib efficacy and safety as salvage treatment following imatinib intolerance and/or inefficacy in steroid refractory chronic graft-versus-host-disease: A prospective, multicenter, phase II study on behalf of the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC). Bone Marrow Transplantation, 58, 401-406. doi:10.1038/s41409-022-01898-x |
Tournilhac, O., van Gelder, M., Eikema, D., van Biezen, A., Dreger, P., Bornhäuser, M., Vucinic, V., Scheid, C., Cornelissen, J., Schroeder, T., Jindra, P., Sengeloev, H., Nguyen, S., Stelljes, M., Blau, I., Mayer, J., Paneesha, S., Chevalier, C., Forcade, E., ... Yakoub-Agha, I. (2023). The European landscape on allogeneic haematopoeietic cell transplantation in Chronic Lymphocytic Leukaemia between 2009-2019: a perspective from the Chronic Malignancies Working Party of the EBMT. Bone Marrow Transplantation, 58, 621-624. doi:10.1038/s41409-023-01955-z |
El Moussaoui, M., Desmecht, S., Tashkeev, A., Lambert, N., Maes, N., Braghini, J., MARECHAL, N., Quintana, C., BRIQUET, K., Gofflot, S., TOUSSAINT, F., Hayette, M.-P., Vermeersch, P., Lutteri, L., Grégoire, C., Beguin, Y., Rahmouni, S., Moutschen, M., Desmecht, D., & Darcis, G. (05 September 2022). Reduced T-cell response following a third dose of SARS-CoV-2 vaccine in infection-naïve people living with HIV. Journal of Infection, 85, 751-755. doi:10.1016/j.jinf.2022.09.006 |
De Voeght, A., WILLEMS, E., Servais, S., Seidel, L., Pirotte, M., Massion, P., Layios, N., Pereira, M., Misset, B., CANIVET, J.-L., Beguin, Y., & Baron, F. (31 August 2022). Overall Survival Rate in Allogeneic Stem Cell Transplanted Patients Requiring Intensive Care Can Be Predicted by the Prognostic Index for Critically Ill Allogeneic Transplantation Patients (PICAT) and the Sequential Organ Failure Assessment (SOFA) Scores. Cancers, 14 (17), 4266. doi:10.3390/cancers14174266 |
Pathak, G. A., Karjalainen, J., Stevens, C., Neale, B. M., Daly, M., Ganna, A., Andrews, S. J., Kanai, M., Cordioli, M., Polimanti, R., Harerimana, N., Pirinen, M., Liao, R. G., Chwialkowska, K., Trankiem, A., Balaconis, M. K., Nguyen, H., Solomonson, M., Veerapen, K., ... Baillie, J. K. (03 August 2022). A first update on mapping the human genetic architecture of COVID-19. Nature, 608, 1-E10. doi:10.1038/s41586-022-04826-7 |
GREGOIRE, C.* , LAYIOS, N.* , LAMBERMONT, B., LECHANTEUR, C., BRIQUET, A., Bettonville, V., BAUDOUX, E., THYS, M., Dardenne, N., Misset, B.* , & BEGUIN, Y.*. (04 July 2022). Bone Marrow-Derived Mesenchymal Stromal Cell Therapy in Severe COVID-19: Preliminary Results of a Phase I/II Clinical Trial. Frontiers in Immunology, 13, 932360. doi:10.3389/fimmu.2022.932360 * These authors have contributed equally to this work. |
Nabergoj, M., Mauff, K., Beelen, D., Ganser, A., Kröger, N., Stölzel, F., Finke, J., Passweg, J., Cornelissen, J., Schub, N., Veelken, J. H., Beguin, Y., Wilson, K., Zuckerman, T., Hunault-Berger, M., Lioure, B., Porras, R. P., Turlure, P., Kerre, T., ... Yakoub-Agha, I. (July 2022). Allogeneic hematopoietic cell transplantation in patients with therapy-related myeloid neoplasm after breast cancer: a study of the Chronic Malignancies Working Party of the EBMT. Bone Marrow Transplantation, 57, 1072 - 1078. doi:10.1038/s41409-022-01686-7 |
El Moussaoui, M., Maes, N., Hong, S. L., Lambert, N., Gofflot, S., DELLOT, P., Belhadj, Y., Huynen, P., Hayette, M.-P., Meex, C., Bontems, S., Defêche, J., Godderis, L., Molenberghs, G., Meuris, C., Artesi, M., Durkin, K., Rahmouni, S., GREGOIRE, C., ... DARCIS, G. (14 June 2022). Evaluation of Screening Program and Phylogenetic Analysis of SARS-CoV-2 Infections among Hospital Healthcare Workers in Liège, Belgium. Viruses, 14 (6), 1302. doi:10.3390/v14061302 |
GREGOIRE, C.* , HUYNEN, P.* , Gofflot, S., Seidel, L., Maes, N., VRANKEN, L., DELCOUR, S., MOUTSCHEN, M., HAYETTE, M.-P., KOLH, P., MELIN, P., & BEGUIN, Y. (13 June 2022). Predictive factors for the presence and long-term persistence of SARS-CoV-2 antibodies in healthcare and university workers. Scientific Reports, 12, 9790. doi:10.1038/s41598-022-13450-4 * These authors have contributed equally to this work. |
SERVAIS, S., BEGUIN, Y., & BARON, F. (27 May 2022). Current Status and Perspectives of Allogeneic Hematopoietic Stem Cell Transplantation in Elderly Patients with Acute Myeloid Leukemia. Stem Cells Translational Medicine, 11 (5), 461-477. doi:10.1093/stcltm/szac015 |
BARZIN, A., Geurten, C., WILLEMS, E., Baron, F., Beguin, Y., & Servais, S. (May 2022). Maladie du greffon contre l’hôte aiguë et chronique après allogreffe de cellules souches hématopoïétiques. Revue Médicale de Liège, 77 (5-6), 345 - 353. |
Canti, L., Ariën, K. K., Desombere, I., Humblet-Baron, S., Pannus, P., Heyndrickx, L., HENRY, A., SERVAIS, S., WILLEMS, E., Ehx, G., Goriely, S., SEIDEL, L., Michiels, J., Willems, B., Goossens, M. E., Beguin, Y., Marchant, A., & Baron, F. (11 April 2022). Antibody response against SARS-CoV-2 Delta and Omicron variants after third-dose BNT162b2 vaccination in allo-HCT recipients. Cancer Cell, 40 (4), 335-337. doi:10.1016/j.ccell.2022.02.005 |
GREGOIRE, C., SERVAIS, S., WILLEMS, E., BAUDOUX, E., LECHANTEUR, C., BRIQUET, A., Bettonville, V., DETRY, O., ERPICUM, P., JOURET, F., LOUIS, E., BARON, F., & BEGUIN, Y. (April 2022). Immunothérapie cellulaire au CHU de Liège : avancées, défis et perspectives. Revue Médicale de Liège, 77 (4), 206-211. |
HUYNEN, P.* , GREGOIRE, C.* , GOFFLOT, S., SEIDEL, L., MAES, N., VRANKEN, L., DELCOUR, S., MOUTSCHEN, M., HAYETTE, M.-P., KOLH, P., MELIN, P., & BEGUIN, Y. (25 March 2022). Long-term longitudinal evaluation of the prevalence of SARS-CoV-2 antibodies in healthcare and university workers. Scientific Reports, 12 (1), 5156. doi:10.1038/s41598-022-09215-8 * These authors have contributed equally to this work. |
Albert, M. H., Sirait, T., Eikema, D.-J., Bakunina, K., Wehr, C., Suarez, F., Fox, M. L., Mahlaoui, N., Gennery, A. R., Lankester, A. C., Beier, R., Bernardo, M. E., Bigley, V., Lindemans, C. A., Burns, S. O., Carpenter, B., Dybko, J., Güngör, T., Hauck, F., ... Vinh, D. C. (2022). Hematopoietic stem cell transplantation for adolescents and adults with inborn errors of immunity: an EBMT IEWP study. Blood, 140, 1635 - 1649. doi:10.1182/blood.2022015506 |
Averbuch, D., De Greef, J., Duréault, A., Wendel, L., Tridello, G., Lebeaux, D., Mikulska, M., Gil, L., Knelange, N., Zuckerman, T., Daguindau, E., Robin, C., Xhaard, A., Aljurf, M., Beguin, Y., Le Bourgeois, A., Botella-Garcia, C., Khanna, N., Van Praet, J., ... Styczynski, J. (2022). Nocardia infections in hematopoietic cell transplant recipients: a multicenter international retrospective study of the Infectious Diseases Working Party (IDWP) of the European Society for Blood and Marrow Transplantation (EBMT). Clinical Infectious Diseases, 75, 88-97. doi:10.1093/cid/ciab866 |
BARON, F., Canti, L., Ariën, K. K., Kemlin, D., Desombere, I., Gerbaux, M., Pannus, P., BEGUIN, Y., Marchant, A., & Humblet-Baron, S. (2022). Insights From Early Clinical Trials Assessing Response to mRNA SARS-CoV-2 Vaccination in Immunocompromised Patients. Frontiers in Immunology, 13, 827242. doi:10.3389/fimmu.2022.827242 |
BAYOUDH, F., JASPERS, A., Azerad, M.-A., SOMJA, J., Marechal, H., & Beguin, Y. (2022). A rare case of massive myocardial infiltration by a disseminated extra-nodal NK/T-cell lymphoma. EJHaem, 3, 547-548. |
Le Calvez, B., Tessoullin, B., Renaud, L., Botella-Garcia, C., Srour, M., Le Gouill, S., Guillerm, G., Gressin, R., Nguyen Quoc, S., Furst, S., Chauchet, A., Sibon, D., Lewalle, P., Poiré, X., Maillard, N., Villate, A., Loschi, M., Paillassa, J., Beguin, Y., ... Le Bourgeois, A. (2022). Outcomes after allogeneic hematopoietic stem cell transplantation for adults with primary mediastinal B cell lymphoma: a SFGM-TC and LYSA study. Acta Oncologica, 61, 1332 - 1338. doi:10.1080/0284186X.2022.2130709 |
Narinx, J., Houbiers, M., Seidel, L., & Beguin, Y. (2022). Adherence to Sars-CoV2 vaccination in hematological patients. Frontiers in Immunology, 13, 994311. doi:10.3389/fimmu.2022.994311 |
Onida, F., Sbianchi, G., Radujkovic, A., Sockel, K., Kröger, N., Sierra, J., Socié, G., Cornelissen, J., Poiré, X., Raida, L., Bourhis, J.-H., Finke, J., Passweg, J., Salmenniemi, U., Schouten, H. C., BEGUIN, Y., Martin, S., Deconinck, E., Ganser, A., ... Yakoub-Agha, I. (2022). Prognostic value of a new clinically-based classification system in patients with CMML undergoing allogeneic HCT: a retrospective analysis of the EBMT-CMWP. Bone Marrow Transplantation, 57, 896-902. doi:10.1038/s41409-021-01555-9 |
Pochon, C., Detrait, M., Dalle, J.-H., Michel, G., Dhédin, N., Chalandon, Y., Brissot, E., Forcade, E., Sirvent, A., Izzadifar-Legrand, F., Michallet, M., Renard, C., Yakoub-Agha, I., Gonzales, F., Bay, J.-O., Kanold, J., Cornillon, J., Bulabois, C. E., Angoso, M., ... Rubio, M.-T. (2022). Improved outcome in children compared to adolescents and young adults after allogeneic hematopoietic stem cell transplant for acute myeloid leukemia: a retrospective study from the Francophone Society of Bone Marrow Transplantation and Cell Therapy (SFGM-TC). Journal of Cancer Research and Clinical Oncology, 148, 2083-2097. doi:10.1007/s00432-021-03761-w |
Poiré, X., Graux, C., ORY, A., Herman, J., Baron, F., Schoemans, H., Lewalle, P., De Becker, A., Deeren, D., Berneman, Z., Kerre, T., Zachée, P., Selleslag, D., & Beguin, Y. (2022). Sequential administration of 5-azacytidine (AZA) and donor lymphocyte infusion (DLI) for patients with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS) in relapse after allogeneic stem cell transplantation (SCT): a prospective study from the Belgian Hematology Society (BHS). Bone Marrow Transplantation, 57, 116-118. doi:10.1038/s41409-021-01464-x |
Teyssier, A.-C., Michel, G., Jubert, C., Rialland, F., Visentin, S., Ouachée, M., Bilger, K., Gandemer, V., Beguin, Y., Marie-Cardine, A., Chalandon, Y., Ansari, M., Baumstarck, K., Loundou, A., Dalle, J.-H., & Sirvent, A. (2022). Unrelated Cord Blood Transplantation in Children, Adolescents, and Young Adults with Acute Leukemia or Myelodysplastic Syndrome: A Retrospective Comparative Study from the French Society for Bone Marrow Transplantation and Cellular Therapy Between Real-World Data and Previously Reported Results of a Randomized Clinical Trial. Transplantation and Cellular Therapy, 28, 780.e1 - 780.e7. doi:10.1016/j.jtct.2022.08.019 |
VANDERMEULEN, M., Mohamed-Wais, M., ERPICUM, P., DELBOUILLE, M.-H., LECHANTEUR, C., BRIQUET, A., MAGGIPINTO, G., Jouret, F., Beguin, Y., & Detry, O. (2022). Infusion of allogeneic mesenchymal stromal cells after liver transplantation: Five-year follow-up. Liver Transplantation, 28, 636-646. doi:10.1002/lt.26323 |
VIEUJEAN, S., LOLY, J.-P., BOUTAFFALA, L., MEUNIER, P., REENAERS, C., BRIQUET, A., LECHANTEUR, C., BAUDOUX, E., BEGUIN, Y., & LOUIS, E. (2022). Mesenchymal Stem Cell Injection in Crohn's Disease Strictures: a phase I-II clinical study. Journal of Crohn's and Colitis, 16, 506-510. doi:10.1093/ecco-jcc/jjab154 |
Bay, J. O., Beguin, Y., CARPENTIER, A., Dard, C., Guillaume, T., Labussiere-Wallet, H., Lacassagne, M. N., Sauze, S., Yakoub-Agha, I., & Chalandon, Y. (2021). Comment faire face à un évènement inattendu pouvant modifier l’activité normale de thérapie cellulaire? Recommandations de la Société Francophone de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC). Bulletin du Cancer, 108, 20-S25. doi:10.1016/j.bulcan.2021.05.002 |
BEGUIN, Y. (2021). L’Institut de Cancérologie Arsène Burny (ICAB) et son nouveau bâtiment du Centre Intégré d’Oncologie (CIO) au CHU de Liège. Revue Médicale de Liège, 76, 300-306. |
Canti, L.* , Humblet-Baron, S.* , Desombere, I., Neumann, J., Pannus, P., Heyndrickx, L., Henry, A., SERVAIS, S., WILLEMS, E., Ehx, G., Goriely, S., Seidel, L., Michiels, J., Willems, B., Liston, A., Ariën, K. K., Beguin, Y., Goossens, M. E., Marchant, A., & Baron, F. (2021). Predictors of neutralizing antibody response to BNT162b2 vaccination in allogeneic hematopoietic stem cell transplant recipients. Journal of hematology & oncology, 14 (1), 174. doi:10.1186/s13045-021-01190-3 * These authors have contributed equally to this work. |
Courtois, J., Ritacco, C., DUBOIS, S., Canti, L., Vandenhove, B., SEIDEL, L., Daulne, C., CAERS, J., SERVAIS, S., Beguin, Y., Ehx, G., & BARON, F. (2021). Itacitinib prevents xenogeneic GVHD in humanized mice. Bone Marrow Transplantation, 56, 2672-2681. doi:10.1038/s41409-021-01363-1 |
DE VOEGHT, A., JASPERS, A., BEGUIN, Y., Baron, F., & DE PRIJCK, B. (2021). Principes généraux de la prise en charges des leucémies aiguës de l’adulte en 2021 en Belgique. Revue Médicale de Liège, 76, 470-475. |
Duray, E., Lejeune, M., Baron, F., Beguin, Y., Devoogdt, N., Krasniqi, A., Lauwers, Y., Zhao, Y. J., D'Huyvetter, M., Dumoulin, M., & Caers, J. (2021). A non-internalised CD38-binding radiolabelled single-domain antibody fragment to monitor and treat multiple myeloma. Journal of hematology & oncology, 14 (1), 183. doi:10.1186/s13045-021-01171-6 |
Ehx, G.* , Ritacco, C.* , HANNON, M., DUBOIS, S., Delens, L., WILLEMS, E., SERVAIS, S., Drion, P., BEGUIN, Y., & Baron, F. (2021). Comprehensive analysis of the immunomodulatory effects of rapamycin on human T cells in graft-versus-host disease prophylaxis. American Journal of Transplantation, 21, 2662-2674. doi:10.1111/ajt.16505 * These authors have contributed equally to this work. |
Janssens, A., Selleslag, D., Depaus, J., BEGUIN, Y., & Lambert, C. (2021). Primary immune thrombocytopenia in adults. Belgian recommendations for diagnosis and treatment anno 2021 made by the Belgian Hematology Society. Acta Clinica Belgica, 26, 1-14. doi:10.1080/17843286.2021.1876310 |
Janssens, A., Selleslag, D., Depaus, J., BEGUIN, Y., & Lambert, C. (2021). Primary immune thrombocytopenia in adults: Belgian recommendations for diagnosis and treatment anno 2021 made by the Belgian Hematology Society. Belgian Journal of Hematology, 12, 112-127. |
Kröger, N., Sbianchi, G., Sirait, T., Wolschke, C., Beelen, D., Passweg, J., Robin, M., Vrhovac, R., Helbig, G., Sockel, K., Conneally, E., Rubio, M. T., Beguin, Y., Finke, J., Bernasconi, P., Morozova, E., Clausen, J., von dem Borne, P., Schaap, N., ... Yakoub-Agha, I. (2021). Impact of prior JAK-inhibitor therapy with ruxolitinib on outcome after allogeneic hematopoietic stem cell transplantation for myelofibrosis: a study of the CMWP of EBMT. Leukemia, 35, 3551-3580. doi:10.1038/s41375-021-01276-4 |
LECHANTEUR, C., BRIQUET, A., Bettonville, V., BAUDOUX, E., & BEGUIN, Y. (2021). MSC Manufacturing for Academic Clinical Trials: From a Clinical-Grade to a Full GMP-Compliant Process. Cells, 10, 1320. doi:10.3390/cells10061320 |
Lejeune, M., Duray, E., Peipp, M., Clémenceau, B., Baron, F., Beguin, Y., & Caers, J. (2021). Balancing the CD38 Expression on Effector and Target Cells in Daratumumab-Mediated NK Cell ADCC against Multiple Myeloma. Cancers, 13 (12), 3072. doi:10.3390/cancers13123072 |
MAQUET, C., BEGUIN, Y., DE PRIJCK, B., WILLEMS, E., SERVAIS, S., & BONNET, C. (2021). Le lymphome diffus à grandes cellules B : nouveau traitement révolutionnaire par des cellules immunitaires génétiquement modifiées appelées «CAR T cells». Revue Médicale de Liège, 76, 476-481. |
Miano, M., Eikema, D.-J., de la Fuente, J., Bosman, P., Ghavamzadeh, A., Smiers, F., Sengeløv, H., Yesilipek, A., Formankova, R., Bader, P., Díaz Pérez, M. Á., Bertrand, Y., Niemeyer, C., Diallo, S., Ansari, M., Bykova, T. A., Faraci, M., Bonanomi, S., Gozdzik, J., ... Dufour, C. (2021). Stem Cell Transplantation for Diamond-Blackfan Anemia. A Retrospective Study on Behalf of the Severe Aplastic Anemia Working Party of the European Blood and Marrow Transplantation Group (EBMT). Transplantation and Cellular Therapy, 27 (3), 274.e1-274.e5. doi:10.1016/j.jtct.2020.12.024 |
Narinx, J., SERVAIS, S., BARON, F., BEGUIN, Y., & WILLEMS, E. (2021). Allogreffes de cellules souches hématopoïétiques : principes généraux et progrès récents. Revue Médicale de Liège, 76, 464-469. |
Niemi, M., Gazon, H., JUSZCZAK, D., FADEUR, M., CAMBY, S., MEURIS, C., THYS, M., JACQUES, J., HENKET, M., BEGUIN, Y., Rahmouni, S., Lebrun, M., MOUTSCHEN, M., Misset, B., DARCIS, G., GUIOT, J., AZARZAR, S., DELLOT, P., GOFFLOT, S., ... HUYNEN, P. (Other coll.). (2021). Mapping the human genetic architecture of COVID-19. Nature, 600, 472-477. doi:10.1038/s41586-021-03767-x |
PIROTTE, M., Fillet, M., SEIDEL, L., JASPERS, A., Baron, F., & Beguin, Y. (2021). Erythroferrone and hepcidin as mediators between erythropoiesis and iron metabolism during allogeneic hematopoietic stem cell transplant. American Journal of Hematology, 96 (10), 1275-1286. doi:10.1002/ajh.26300 |
Ritacco, C.* , Ehx, G.* , GREGOIRE, C., Daulne, C., WILLEMS, E., SERVAIS, S., BEGUIN, Y., & Baron, F. (2021). High proportion of terminally-differentiated regulatory T cells after allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplantation, 56, 1828-1841. doi:10.1038/s41409-021-01221-0 * These authors have contributed equally to this work. |
SCHEEN, A., BEGUIN, Y., & JERUSALEM, G. (2021). L’oncologie, à un tournant de son histoire. Revue Médicale de Liège, 76, 297-299. |
Vrancken, L., Lejeune, M., PIROTTE, M., Duray, E., Köse, M. C., BEGUIN, Y., & CAERS, J. (2021). Le myélome multiple : un tour d’horizon des nouveautés dans sa biologie et son traitement. Revue Médicale de Liège, 76, 482-488. |
Xhaard, A., Xhaard, C., d'Aveni, M., Salvator, H., Chabi-Charvillat, M.-L., Coman, T., BEGUIN, Y., Chalandon, Y., Poiré, X., Loschi, M., Paillard, C., Bruno, B., Ceballos, P., Dalle, J.-H., Bilger, K., Bay, J.-O., Robin, M., N'Guyen-Quoc, S., & Rubio, M.-T. (2021). Risk factors for a severe form of COVID-19 after allogeneic haematopoietic stem cell transplantation : a SFGM-TC multicentre cohort study. British Journal of Haematology, 192, 121-e135. doi:10.1111/bjh.17260 |
Lejeune, M., Köse, M. C., Duray, E., Einsele, H., Beguin, Y., & Caers, J. (07 May 2020). Bispecific, T-Cell-Recruiting Antibodies in B-Cell Malignancies. Frontiers in Immunology, 11 (762), 1-20. doi:10.3389/fimmu.2020.00762 |
Azerad, M.-A., BAYOUDH, F., Weber, T., Minon, J.-M., Ketelsleggers, O., HOYOUX, M., Ren, X., Kaye, O., De Marneffe, N., Fraipont, V., Masset, C., Bouillon, A.-S., JASPERS, A., Tebache, M., D'Hoen, G., Habibi, A., Efira, A., Thachil, J., Deckmyn, H., & BEGUIN, Y. (2020). Sickle cell disease and COVID-19: Atypical presentations and favorable outcomes. EJHaem, 1 (jha 2.74), 338-341. doi:10.1002/jha2.74 |
Dhédin, N., Paillard, C., Dalle, J.-H., Ouachée, M., Buchbinder, N., Brissot, E., BEGUIN, Y., Masouridi-Levrat, S., Yakoub-Agha, I., Bernit, E., & Pondarre, C. (2020). Allogreffe de cellules souches hématopoïétiques dans la drépanocytose de l'enfant et de l'adulte : indications et modalités. Bulletin du Cancer, 107, 925-933. doi:10.1016/j.bulcan.2020.06.003 |
Dubois, V., Amokrane, K., Beguin, Y., Bruno, B., Chevallier, P., Delbos, F., Devillier, R., Giannoli, C., Guidicelli, G., Harif, M., Loiseau, P., Rouzaire, P.-O., Varlet, P., Yakoub-Agha, I., & Nguyen, S. (2020). Greffe de cellules souches hématopoïétiques haplo-identiques avec cyclophosphamide en post-greffe : comment choisir le meilleur donneur en 2019 ? Recommandations de la Société francophone de greffe de mœlle et de thérapie cellulaire (SFGM-TC). Bulletin du Cancer, 107 (Suppl. 1), 72-84. doi:10.1016/j.bulcan.2019.07.011 |
HAUZEUR, J.-P., LECHANTEUR, C., BAUDOUX, E., De Maertelaer, V., Pather, S., Katz, R., Malaise, M., Ino, J., & Beguin, Y. (2020). Did Osteoblastic Cell Therapy Improve the Prognosis of Prefracture Osteonecrosis of the Femoral Head? A Randomized, Controlled Trial. Clinical Orthopaedics and Related Research, 478, 1307-1315. |
Lejeune, M., Köse, M. C., Duray, E., Beguin, Y., & CAERS, J. (2020). Les anticorps bispécifiques ciblant les lymphocytes T dans le myélome multiple. OncoHemato : Revue Multidisciplinaire d'Oncologie et Hématologie, 14 (6), 30-34. |
Mamez, A.-C., Dupont, A., Blaise, D., Chavallier, P., Forcade, E., Ceballos, P., Mohty, M., Suarez, F., BEGUIN, Y., Peffault de Latour, R., Rubio, M.-T., Tournilhac, O., & Nguyen, S. (2020). Allogeneic stem cell transplantation for peripheral T cell lymphomas: a retrospective study in 285 patients from the Société Francophone de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC). Journal of Hematology and Oncology, 13, 56. doi:10.1186/s13045-020-00892-4 |
Roex, G., Feys, T., BEGUIN, Y., Kerre, T., Poiré, X., Lewalle, P., Vandenberghe, P., Bron, D., & Anguille, S. (2020). Chimeric Antigen Receptor-T-Cell Therapy for B-Cell Hematological Malignancies : An Update of the Pivotal Clinical Trial Center. Pharmaceutics, 12, 194. doi:10.3390/pharmaceutics12020194 |
Snowden, J. A., Saccardi, R., Orchard, K., Ljungman, P., Duarte, R. F., Labopin, M., McGrath, E., Brook, N., Ruiz de Elvira, C., Gordon, D., Poirel, H. A., Ayuk, F., Beguin, Y., Bonifazi, F., Gratwohl, A., Milpied, N., Moore, J., Passweg, J., Rizzo, J. D., ... Putter, H. (2020). Benchmarking of Survival Outcomes following Haematopoietic Stem Cell Transplantation: A review of existing processes and the introduction of an international system from the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE). Bone Marrow Transplantation, 55, 681-694. doi:10.1038/s41409-019-0718-7 |
Antoine-Poirel, H., Vanspauwen, M., Macq, G., De Geyndt, A., Maertens, J., WILLEMS, E., Selleslag, D., Poiré, X., Theunissen, K., Graux, C., Kerre, T., Zachée, P., Meuleman, N., De Becker, A., Verlinden, A., Van Obbergh, F., Schuermans, C., De Wilde, V., JASPERS, A., ... Beguin, Y. (2019). Providing both autologous and allogeneic hematopoietic stem cell transplants (HSCT) may have a stronger impact on the outcome of autologous HSCT in adult patients than activity levels or implementation of JACIE at Belgian transplant centres. Bone Marrow Transplantation, 54, 1434-1442. doi:10.1038/s41409-019-0458-8 |
Caulier, A., Drumez, E., Gauthier, J., Robin, M., Blaise, D., Beguin, Y., Michallet, M., Chevallier, P., Bay, J.-O., Vigouroux, S., Desbrosses, Y., Cornillon, J., Nguyen, S., Dauriac, C., de Latour, R. P., Lioure, B., Rohrlich, P.-S., Carré, M., Bourhis, J.-H., ... Yakoub-Agha, I. (2019). Scoring System Based on Post-Transplant Complications in Patients after Allogeneic Hematopoietic Cell Transplantation for Myelodysplastic Syndrome: A Study from the SFGM-TC. Current Research in Translational Medicine, 67, 8-15. doi:10.1016/j.retram.2018.08.003 |
Cremers, E., de Witte, T., de Wreede, L., Eikema, D.-J., Koster, L., van Biezen, A., Finke, J., Socié, G., Beelen, D., Maertens, J., Nagler, A., Kobbe, G., Ziagkos, D., Itälä-Remes, M., Gedde-Dahl, T., Sierra, J., Niederwieser, D., Ljungman, P., Beguin, Y., ... Kröger, N. (2019). A prospective non-interventional study on the impact of transfusion burden and related iron toxicity on outcome in myelodysplastic syndromes undergoing allogeneic hematopoietic cell transplantation *. Leukemia and Lymphoma, 60, 2404-2414. doi:10.1080/10428194.2019.1594215 |
Delens, L., Ehx, G., SOMJA, J., Vrancken, L., Belle, L., SEIDEL, L., Grégoire, C., Fransolet, G., Ritacco, C., Hannon, M., DUBOIS, S., Beguin, Y., Baron, F., & Servais, S. (2019). In Vitro Th17-Polarized Human CD4(+) T Cells Exacerbate Xenogeneic Graft-versus-Host Disease. Biology of Blood and Marrow Transplantation, 25, 204-215. doi:10.1016/j.bbmt.2018.10.007 |
Engel, N., Rovo, A., Badoglio, M., Labopin, M., Basak, G. W., BEGUIN, Y., Guyotat, D., Ljungman, P., Nagler, A., Schattenberg, A., Schroeder, T., Schroyens, W., Tischer, J., Socie, G., Kolb, H.-J., Tichelli, A., Salooja, N., & Duarte, R. F. (2019). European experience and risk factor analysis of donor cell-derived leukaemias/MDS following haematopoietic cell transplantation. Leukemia, 33, 508-517. doi:10.1038/s41375-018-0218-6 |
Fayard, A., Daguenet, E., Blaise, D., Chevallier, P., Labussière, H., Berceanu, A., Yakoub-Agha, I., Socié, G., Charbonnier, A., Suarez, F., Huynh, A., Mercier, M., Bulabois, C.-E., Lioure, B., Chantepie, S., Beguin, Y., Bourhis, J.-H., Malfuson, J.-V., Clément, L., ... Cornillon, J. (2019). Evaluation of infectious complications after haploidentical hematopoietic stem cell transplantation with post-transplant cyclophosphamide following reduced-intensity and myeloablative conditioning: a study on behalf of the Francophone Society of Stem Cell Transplantation and Cellular Therapy (SFGM-TC). Bone Marrow Transplantation, 54, 1586-1594. doi:10.1038/s41409-019-0475-7 |
Feyx, T., Roex, G., Beguin, Y., Kerre, T., Poiré, X., Lewalle, P., Vandenberghe, P., Bron, D., & Anguille, S. (2019). Chimeric antigen receptor T-cells: a new therapeutic option for relapsed/refractory B-cell malignancies and beyond. Belgian Journal of Hematology, 10, 301-310. |
Fitzgerald, S. P., Grote Beverborg, N., Beguin, Y., Artunc, F., Falhammar, H., & Bean, N. G. (2019). Population data provide evidence against the presence of a set point for hemoglobin levels or tissue oxygen delivery. Physiological Reports, 7 (12), 14153. doi:10.14814/phy2.14153 |
Grégoire, C., Ritacco, C., Hannon, M., SEIDEL, L., Delens, L., Belle, L., DUBOIS, S., Veriter, S., LECHANTEUR, C., BRIQUET, A., Servais, S., Ehx, G., Beguin, Y., & Baron, F. (2019). Comparison of Mesenchymal Stromal Cells From Different Origins for the Treatment of Graft-vs.-Host-Disease in a Humanized Mouse Model. Frontiers in Immunology, 10, 619. doi:10.3389/fimmu.2019.00619 |
Jaimes-Albornoz, D., Mannone, L., Nguyen-Quoc, S., Chalandon, Y., Chevallier, P., Mohty, M., Meunier, M., Robin, M., Ledoux, M.-P., Guillerm, G., Bay, J.-O., Poiré, X., Maillard, N., Leclerc, M., Daguindau, E., Beguin, Y., Rubio, M. T., & Gyan, E. (2019). Allogeneic Stem Cell Transplantation in Therapy-Related Myelodysplasia after Autologous Transplantation for Lymphoma: A Retrospective Study of the Francophone Society of Bone Marrow Transplantation and Cellular Therapy. Biology of Blood and Marrow Transplantation, 25, 2366-2374. doi:10.1016/j.bbmt.2019.07.013 |
JASPERS, A., & Beguin, Y. (2019). Erythropoiesis and iron metabolism after hematopoietic stem cell transplantation. Belgian Journal of Hematology, 10, 89-95. |
Muller, J., Duray, E., Lejeune, M., DUBOIS, S., Plougonven, E., Léonard, A., Storti, P., Giuliani, N., Cohen-Solal, M., Hempel, U., Thijssen, V., BEGUIN, Y., Heusschen, R., & CAERS, J. (2019). Loss of stromal galectin-1 enhances multiple myeloma development: Emphasis on a role in osteoclasts. Cancers, 11 (2), 261. doi:10.3390/cancers11020261 |
Nagler, A., Labopin, M., Dholaria, B., Niittyvuopio, R., Maertens, J., Poiré, X., Cornelissen, J., Reményi, P., Bourhis, J. H., Beguin, Y., Malladi, R., Kerre, T., Schroyens, W., Savani, B. N., & Mohty, M. (2019). Impact of antithymocyte globulin on outcomes of allogeneic hematopoietic cell transplantation with TBI. Blood Advances, 3 (13), 1950-1960. doi:10.1182/bloodadvances.2019000030 |
WITHOFS, N., Beguin, Y., COUSIN, F., Tancredi, T., SIMONI, P., Alvarez-Miezentseva, V., DE PRIJCK, B., HAFRAOUI, K., Bonnet, C., Baron, F., Hustinx, R., & Caers, J. (2019). Dual-tracer PET/CT scan after injection of combined [ 18 F]NaF and [ 18 F]FDG outperforms MRI in the detection of myeloma lesions. Hematological Oncology, 37, 193-201. doi:10.1002/hon.2600 |
Zephir, H., Puyade, M., Gueguen, A., Michel, L., Terriou, L., Dive, D., Laureys, G., Mathey, G., Labauge, P., Marjanovic, Z., Pugnet, G., Badoglio, M., Lansiaux, P., Ibrahim, Y.-A., Beguin, Y., & Farge, D. (2019). Indications de l'autogreffe dans la sclérose en plaques : recommandations de la Société francophone de greffe de moelle et de thérapie cellulaire (SFGM-TC) en lien avec la Société francophone de la sclérose en plaques. Bulletin du Cancer, 106 (Suppl. 1), 92-101. doi:10.1016/j.bulcan.2018.11.002 |
Farhat, K., Bodart, G., Charlet-Renard, J. D. C., Desmet, C., Moutschen, M., Beguin, Y., Baron, F., Melin, P., Quatresooz, P., Parent, A.-S., Desmecht, D., Sirard, J.-C., Salvatori, R., Martens, H., & Geenen, V. (02 October 2018). Growth hormone (GH) deficient mice with GHRH ablation are severely deficient in vaccine and immune responses against Streptococcus pneumoniae. Frontiers in Immunology, 9, 2175. doi:10.3389/fimmu.2018.02175 |
Aapro, M. S., Beguin, Y., Bokemeyer, C., Dicato, M., Gascon, P., Glaspy, J. A., Hofmann, A., Link, H., Littlewod, T., Ludwig, H., Osterborg, A., Pronzato, P., Santini, V., Schrijvers, D., Stauder, R., & Herrstedt, J. (2018). Management of anaemia and iron deficiency in patients with cancer : ESMO Clinical Practice Guidelines. Annals of Oncology, 29, 96-110. doi:10.1093/annonc/mdx758 |
Akhtar, S., Montoto, S., Boumendil, A., Finel, H., Masszi, T., Jindra, P., Nemet, D., Fuhrmann, S., Beguin, Y., Castagna, L., Ferrara, F., Capria, S., Malladi, R., Moraleda, J. M., Bloor, A., Ghesquières, H., Meissner, J., Sureda, A., & Dreger, P. (2018). High dose chemotherapy and autologous stem cell transplantation in nodular lymphocyte-predominant Hodgkin lymphoma: A retrospective study by the European society for blood and marrow transplantation-lymphoma working party. American Journal of Hematology, 93 (1), 40-46. doi:10.1002/ajh.24927 |
Caers, J., Garderet, L., Kortum, K. M., O'Dwyer, M. E., van de Donk, N. W. C. J., Binder, M., Dold, S. M., Gay, F., Corre, J., Beguin, Y., Ludwig, H., Larocca, A., Driessen, C., Dimopoulos, M. A., Boccadoro, M., Gramatzki, M., Zweegman, S., Einsele, H., Cavo, M., ... Engelhardt, M. (2018). European Myeloma Network recommendations on tools for the diagnosis and monitoring of multiple myeloma: what to use and when. Haematologica, 103, 1172-1184. doi:10.3324/haematol.2018.189159 |
Decroocq, J., Itzykson, R., Vigouroux, S., Michallet, M., Yakoub-Agha, I., Huynh, A., Beckerich, F., Suarez, F., Chevallier, P., Nguyen-Quoc, S., Ledoux, M.-P., Clement, L., Hicheri, Y., Guillerm, G., Cornillon, J., Contentin, N., Carre, M., Maillard, N., Mercier, M., ... Dhedin, N. (2018). Similar outcome of allogeneic stem cell transplantation after myeloablative and sequential conditioning regimen in patients with refractory or relapsed acute myeloid leukemia: A study from the Societe Francophone de Greffe de Moelle et de Therapie Cellulaire. American Journal of Hematology, 93 (3), 416-423. doi:10.1002/ajh.25004 |
Devos, T., BEGUIN, Y., Noens, L., Van Eygen, K., Zachée, P., Mineur, P., Knoops, L., Doyen, C., Theunissen, K., Benghiat, F. S., Reusens, M., & Pluymers, W. (2018). Disease and treatment characteristics of polycythaemia vera patients in Belgium : results from a scientific survey. European Journal of Haematology, 100, 361-366. doi:10.1111/ejh.13022 |
Ehx, G., SOMJA, J., Warnatz, H.-J., Ritacco, C., HANNON, M., Delens, L., Fransolet, G., DELVENNE, P., Muller, J., BEGUIN, Y., Lehrach, H., Belle, L., Humblet-Baron, S., & BARON, F. (2018). Xenogeneic graft-versus-host disease in humanized NSG and NSG-HLA-A2/HHD mice. Frontiers in Immunology, 9, 1943. doi:10.3389/fimmu.2018.01943 |
Gauthier, J., Poiré, X., Gac, A.-C., Leclerc, M., Guillaume, T., Chalandon, Y., Nguyen, S., Forcade, E., Régny, C., Bay, J.-O., Bazarbachi, A., Rohrlich, P.-S., Huynh, A., Farhi, J., Marchand, T., Malfuson, J.-V., Pilorge, S., Labussière-Wallet, H., Renard, C., ... Yakoub-Agha, I. (2018). Better outcome with haploidentical over HLA-matched related donors in patients with Hodgkin's lymphoma undergoing allogeneic haematopoietic cell transplantation - A study by the Francophone Society of Bone Marrow Transplantation and Cellular Therapy. Bone Marrow Transplantation, 53 (4), 400-409. doi:10.1038/s41409-017-0018-z |
HAUZEUR, J.-P., De Maertelaer, V., BAUDOUX, E., MALAISE, M., Beguin, Y., & Gangji, V. (2018). Inefficacy of autologous bone marrow concentrate in stage three osteonecrosis: a randomized controlled double-blind trial. International Orthopaedics, 42, 1429-1435. doi:10.1007/s00264-017-3650-8 |
Laureys, G., Willekens, B., Vanopdenbosch, L., Deryck, O., Selleslag, D., D'Haeseleer, M., De Becker, A., Dubois, B., Dierickx, D., Perrotta, G., De Wilde, V., van Pesch, V., Straetmans, N., Dive, D., Beguin, Y., Van Wijmeersch, B., Theunissen, K., Kerre, T., & Van de Velde, A. (2018). A Belgian consensus protocol for autologous hematopoietic stem cell transplantation in multiple sclerosis. Acta Neurologica Belgica, 118 (2), 161-168. doi:10.1007/s13760-018-0905-0 |
Lewalle, P., & Beguin, Y. (2018). Extracorporeal photochemotherapy for graft versus host disease : Where we are now and where are we going ! Belgian Journal of Hematology, 9, 254-265. |
McLornan, D. P., Szydlo, R., Robin, M., van Biezen, A., Koster, L., Blok, H. J. P., Van Lint, M. T., Finke, J., Vitek, A., Carlson, K., Griskevicius, L., Holler, E., Itala-Remes, M., Schaap, M., Socie, G., Bay, J.-O., BEGUIN, Y., Bruno, B., Cornelissen, J. J., ... Kroger, N. (2018). Outcome of patients with Myelofibrosis relapsing after allogeneic stem cell transplant: a retrospective study by the Chronic Malignancies Working Party of EBMT. British Journal of Haematology, 182, 418-422. doi:10.1111/bjh.15407 |
Muller, J., Bolomsky, A., Dubois, S., Duray, E., Stangelberger, K., Plougonven, E., Lejeune, M., Léonard, A., Marty, C., Hempel, U., Baron, F., BEGUIN, Y., Cohen-Solal, M., Ludwig, H., Heusschen, R., & CAERS, J. (2018). Maternal embryonic leucine zipper kinase inhibitor OTSSP167 has preclinical activity on multiple myeloma bone disease. Haematologica, 103, 1359-1368. doi:10.3324/haematol.2017.185397 |
Paviglianiti, A., Tozatto Maio, K., Rocha, V., Gehlkopf, E., Milpied, N., Esquirol, A., Chevallier, P., Blaise, D., Gac, A.-C., Leblond, V., Cahn, J. Y., Abecasis, M., Zuckerman, T., Schouten, H., Gurman, G., Rubio, M. T., Beguin, Y., Corral, L. L., Nagler, A., ... Ruggeri, A. (2018). Outcomes of Advanced Hodgkin Lymphoma after Umbilical Cord Blood Transplantation: A Eurocord and EBMT Lymphoma and Cellular Therapy & Immunobiology Working Party Study. Biology of Blood and Marrow Transplantation, 24, 2265-2270. doi:10.1016/j.bbmt.2018.07.019 |
Pirotte, M.* , Forte, F.* , Lutteri, L., WILLEMS, E., DURAN, U., Belle, L., Baron, F., BEGUIN, Y., Maquet, P., BODART, O.* , & Servais, S.*. (2018). Neuronal surface antibody-mediated encephalopathy as manifestation of chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. Journal of Neuroimmunology, 323, 115-118. doi:10.1016/j.jneuroim.2018.08.003 * These authors have contributed equally to this work. |
Trento, C., Bernardo, M. E., Nagler, A., Kuçi, S., Bornhäuser, M., Köhl, U., Strunk, D., Galleu, A., Sanchez-Guijo, F., Gaipa, G., Introna, M., Bukauskas, A., Le Blanc, K., Apperley, J., Roelofs, H., Van Campenhout, A., Beguin, Y., Kuball, J., Lazzari, L., ... Dazzi, F. (2018). Manufacturing Mesenchymal Stromal Cells for the Treatment of Graft-versus-Host Disease: A Survey among Centers Affiliated with the European Society for Blood and Marrow Transplantation. Biology of Blood and Marrow Transplantation, 24, 2365-2370. doi:10.1016/j.bbmt.2018.07.015 |
Van de Velde, A., Willekens, B., Vanopdenbosch, L., Deryck, O., Selleslag, D., D'Haeseleer, M., De Becker, A., Dubois, B., Dierickx, D., Perrotta, G., De Wilde, V., van Pesch, V., Straetmans, N., Dive, D., Beguin, Y., Van Wijmeersch, B., Theunissen, K., Kerre, T., & Laureys, G. (2018). A Belgian consensus protocol for autologous haematopoietic stem cell transplantation in multiple sclerosis. Belgian Journal of Hematology, 9, 167-174. |
DETRY, O., VANDERMEULEN, M., DELBOUILLE, M.-H., SOMJA, J., BLETARD, N., Briquet, A., LECHANTEUR, C., GIET, O., BAUDOUX, E., Hannon, M., Baron, F., & Beguin, Y. (July 2017). Infusion of mesenchymal stromal cells after deceased liver transplantation: A phase I-II, open-label, clinical study. Journal of Hepatology, 67 (1), 47-55. doi:10.1016/j.jhep.2017.03.001 |
Averbuch, D., Tridello, G., Hoek, J., Mikulska, M., Akan, H., Yaňez San Segundo, L., Pabst, T., Özçelik, T., Klyasova, G., Donnini, I., Wu, D., Gülbas, Z., Zuckerman, T., Botelho De Sousa, A., Beguin, Y., Xhaard, A., Bachy, E., Ljungman, P., De La Camara, R., ... Cesaro, S. (2017). Antimicrobial Resistance in Gram-Negative Rods Causing Bacteremia in Hematopoietic Stem Cell Transplant Recipients: Intercontinental Prospective Study of the Infectious Diseases Working Party of the European Bone Marrow Transplantation Group. Clinical Infectious Diseases, 65 (11), 1819-1828. doi:10.1093/cid/cix646 |
Ehx, G., Fransolet, G., De Leval, L., D'Hondt, S., Lucas, S., Hannon, M., Delens, L., DUBOIS, S., Drion, P., Beguin, Y., Humblet-Baron, S., & Baron, F. (2017). Azacytidine prevents experimental xenogeneic graft-versus-host disease without abrogating graft-versus-leukemia effects. Oncoimmunology, 6:e1314425. doi:10.1080/2162402X.2017.1314425 |
Gauthier, J., Castagna, L., Garnier, F., Guillaume, T., Socié, G., Maury, S., Maillard, N., Tabrizi, R., Marchand, T., Malfuson, J.-V., Gac, A.-C., Gyan, E., Mercier, M., BEGUIN, Y., Delage, J., Turlure, P., Marcais, A., Nguyen, S., Dulery, R., ... Blaise, D. (2017). Reduced intensity and non-myeloablative allogenic stem cell transplantation from alternative HLA-mismatched donors for Hodgkin's lymphoma: a study by the French Society of Bone Marrow Transplantation and Cellular Therapy. Bone Marrow Transplantation, 52, 689-696. doi:10.1038/bmt.2016.34 |
GREGOIRE, C., LECHANTEUR, C., BRIQUET, A., BAUDOUX, E., BARON, F., LOUIS, E., & BEGUIN, Y. (2017). Review article: mesenchymal stromal cell therapy for inflammatory bowel diseases. Alimentary Pharmacology and Therapeutics, 45, 205-221. doi:10.1111/apt.13864 |
Heidenreich, S., Ziagkos, D., De Wreede, L., Van Biezen, A., Finke, J., Platzbecker, U., Niederwieser, D., Einsele, H., Bethge, W., Schleuning, M., Beelen, D., Tischer, J., Nagler, A., Glass, B., Maertens, J., Yanez, L., BEGUIN, Y., Sill, H., Scheid, C., ... Kröger, N. (2017). Allogeneic stem cell transplantation for patients with myelodysplastic syndrome 70 years of age or older: A retrospective study of the MDS subcommittee of the Chronic Malignancies Working Party (CMWP) of the EBMT. Biology of Blood and Marrow Transplantation, 23, 44-52. doi:10.1016/j.bbmt.2016.09.027 |
Heusschen, R., Muller, J., WITHOFS, N., BARON, F., BEGUIN, Y., & CAERS, J. (2017). Multiple myeloma bone disease: from mechanisms to next generation therapy. Belgian Journal of Hematology, 8, 66-74. |
Libert, Y., Borghgraef, C., Beguin, Y., Delvaux, N., DEVOS, M., Doyen, C., Dubruille, S., Etienne, A.-M., Liénard, A., Merckaert, I., Reynaert, C., Slachmuylder, J.-L., Straetmans, N., Van Den Neste, E., Bron, D., & Razavi, D. (2017). Cognitive compensatory processes of older, clinically fit patients with hematologic malignancies undergoing chemotherapy: A longitudinal cohort study. Psycho-oncology, 26 (12), 2086-2093. doi:10.1002/pon.4424 |
Libert, Y., Borghgraef, C., BEGUIN, Y., Delvaux, N., DEVOS, M., Doyen, C., Dubruille, S., Etienne, A.-M., Lienard, A., Merckaert, I., Slachmuylder, J., Straetmans, N., Van Den Neste, E., Bron, D., & Razavi, D. (2017). Factors associated with self-perceived burden to the primary caregiver in older patients with hematologic malignancies: an exploratory study. Psycho-oncology, 26, 118-124. doi:10.1002/pon.4108 |
Magro, L., Forcade, E., Giraud, C., Granata, A., Parquet, N., Rohrlich, P.-S., Terriou, L., Yakoub-Agha, I., & Beguin, Y. (2017). Prise en charge de la maladie du greffon contre l'hôte chronique : Recommandations de la Société francophone de greffe de moelle et de thérapie cellulaire (SFGM-TC). Bulletin du Cancer, 104S, 145-S168. doi:10.1016/j.bulcan.2017.10.023 |
Roth-Guepin, G., Canaani, J., Ruggeri, A., Labopin, M., Finke, J., Cornelissen, J. J., Delage, J., Stuhler, G., Rovira, M., Potter, M., Stadler, M., Veelken, H., Cahn, J. Y., Collin, M., Beguin, Y., Giebel, S., Nagler, A., & Mohty, M. (2017). Allogeneic stem cell transplantation in acute lymphoblastic leukemia patients older than 60 years: A survey from the acute leukemia working party of EBMT. Oncotarget, 8 (68), 112972-112979. doi:10.18632/oncotarget.22934 |
Roux, C., Tifratene, K., Socié, G., Galambrun, C., Bertrand, Y., Rialland, F., Jubert, C., Pochon, C., Paillard, C., Sirvent, A., Nelken, B., Vannier, J.-P., Freycon, C., BEGUIN, Y., Raus, N., Yakoub-Agha, I., Mohty, M., Dalle, J.-H., Michel, G., ... Rohrlich, P.-S. (2017). Outcome after failure of allogeneic hematopoietic stem cell transplantation in children with acute leukemia: a study by the Société Francophone de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC). Bone Marrow Transplantation, 52, 678-682. doi:10.1038/bmt.2016.360 |
SERVAIS, S., Hannon, M., Peffault de Latour, R., Socie, G., & BEGUIN, Y. (2017). Reconstitution of adaptive immunity after umbilical cord blood transplantation and clinical implication regarding risk of infections. Stem Cell Investigation, 4, 40. |
Sticca, T., CABERG, J.-H., Wenric, S., Poulet, C., HERENS, C., JAMAR, M., Josse, C., El Guendi, S., MAX, S., BEGUIN, Y., GOTHOT, A., CAERS, J., & Bours, V. (2017). Genomic Studies of Multiple Myeloma Reveal an Association between X Chromosome Alterations and Genomic Profile Complexity. Genes, Chromosomes and Cancer, 56, 18-27. doi:10.1002/gcc.22397 |
Van Obbergh, F., Knoops, L., Devos, T., BEGUIN, Y., Graux, C., Benghiat, S., Kargar-Samani, K., Bauwens, D., Efira, A., Dubois, C., Springael, C., Montfort, L., Connerotte, T., Delannoy, A., & Wallemacq, P. (2017). The clinical relevance of imatinib plasma trough concentrations in chronic myeloid leukemia. A Belgian study. Clinical Biochemistry, 50, 452-454. doi:10.1016/j.clinbiochem.2016.12.006 |
Vrancken, L., Delens, L., BEGUIN, Y., BARON, F., & SERVAIS, S. (2017). Focus sur les lymphocytes T dans la maladie du greffon contre l'hôte après allogreffe de cellules soucges hématopoïétiques: implications pour de nouvelles stratégies de prévention. OncoHemato : Revue Multidisciplinaire d'Oncologie et Hématologie, 11, 23-31. |
WITHOFS, N., COUSIN, F., DE PRIJCK, B., Bonnet, C., Hustinx, R., Gambhir, S. S., Beguin, Y., & Caers, J. (2017). A First Report on [(18)F]FPRGD2 PET/CT Imaging in Multiple Myeloma. Contrast Media and Molecular Imaging, 2017, 6162845. doi:10.1155/2017/6162845 |
Belle, L.* , Fransolet, G.* , Somja, J., BINSFELD, M., Delvenne, P., Drion, P., Hannon, M., BEGUIN, Y., Ehx, G.* , & Baron, F.*. (12 December 2016). Limited Impact of Imatinib in a Murine Model of Sclerodermatous Chronic Graft-versus-Host Disease. PLoS ONE, 11, 0167997. doi:10.1371/journal.pone.0167997 * These authors have contributed equally to this work. |
Fransolet, G.* , Ehx, G.* , SOMJA, J., Delens, L., Hannon, M., Muller, J., DUBOIS, S., Drion, P., CAERS, J., Humblet-Baron, S., DELVENNE, P., BEGUIN, Y., Conteduca, G.* , & BARON, F.*. (04 July 2016). Azacytidine mitigates experimental sclerodermic chronic graft-versus-host disease. Journal of Hematology and Oncology, 9, 53. doi:10.1186/s13045-016-0281-2 * These authors have contributed equally to this work. |
SERVAIS, S., BEGUIN, Y., Delens, L., Ehx, G., Fransolet, G., Hannon, M., WILLEMS, E., Humblet-Baron, S., Belle, L., & Baron, F. (11 May 2016). Novel approaches for preventing acute graftversus- host disease after allogeneic hematopoietic stem cell transplantation. Expert Opinion on Investigational Drugs, 9, 957-972. doi:10.1080/13543784.2016.1182498 |
Grégoire, C., GUIOT, J., Vertenoeil, G., WILLEMS, E., HAFRAOUI, K., CORHAY, J.-L., LOUIS, R., & BEGUIN, Y. (February 2016). Yellow nail syndrome after allogeneic haematopoietic stem cell transplantation in two patients with multiple myeloma. Acta Clinica Belgica, 71, 428-430. doi:10.1080/17843286.2015.1122872 |
Baron, F., & Beguin, Y. (2016). Prophylactic donor lymphocyte infusion in patients with high-risk acute myeloid leukemia: ready for prime time? Bone Marrow Transplantation, 51, 640-42. doi:10.1038/bmt.2016.38 |
Binsfeld, M., Muller, J., Lamour, V., De Veirman, K., De Raeve, H., Bellahcene, A., Van Valckenborgh, E., BARON, F., BEGUIN, Y., CAERS, J., & Heusschen, R. (2016). Granulocytic myeloid-derived suppressor cells promote angiogenesis in the context of multiple myeloma. Oncotarget, 7, 37931-37943. doi:10.18632/oncotarget.9270 |
El Cheikh, J., Sfumato, P., Sobh, M., Fegueux, N., Mohty, M., Vigouroux, S., BEGUIN, Y., Yakoub-Agha, I., Socié, G., Cornillon, J., Mercier, M., Bay, J., Blaise, D., Michallet, M., & Peffault de Latour, R. (2016). Allogenic hematopoietic stem cell transplantation after reduced intensity conditioning regimen for elderly patients (60 years and older) with hematologic malignancies using unrelated donors: a retrospective study for the French society for stem cell transplantation (SFGM-TC). Haematologica, 101, 262-265. |
Guièze, R., Damaj, G., Pereira, B., Robin, M., Chevallier, P., Michallet, M., Vigouroux, S., BEGUIN, Y., Blaise, D., Roosweil, D., Thiebaut, A., Rohrlich, P.-S., Huynh, A., Cornillon, J., Contentin, N., Suarez, F., Lioure, B., Mohty, M., Maillard, N., ... yakoub-Agha, I. (2016). Management of Myelodysplastic Syndrome Relapsing after Allogeneic Hematopoietic Stem Cell Transplantation: A Study by the French Society of Bone Marrow Transplantation and Cell Therapies. Biology of Blood and Marrow Transplantation, 22, 240-247. doi:10.1016/j.bbmt.2015.07.037 |
Heusschen, R.* , Muller, J.* , Binsfeld, M., Marty, C., Plougonven, E., DUBOIS, S., Mahli, N., Moermans, K., Carmeliet, G., Léonard, A., BARON, F., BEGUIN, Y., Menu, E., Cohen-Solal, M., & CAERS, J. (2016). SRC Kinase Inhibition with Saracatinib Limits the Development of Osteolytic Bone Disease in Multiple Myeloma. Oncotarget, 7, 30712-30729. doi:10.18632/oncotarget.8750 * These authors have contributed equally to this work. |
JASPERS, A., Bouhya, S., Belaiche, S., Chevallier, P., Hermet, E., Hospital-Gustems, C., Michallet, M., Rialland, F., Samsonova, O., Sirvent, A., Yakoub-Agha, I., Rohrlich, P.-S., & BEGUIN, Y. (2016). Evaluation et prise en charge de la surcharge en fer post-greffe recommandations de la SFGM-TC. Bulletin du Cancer, 103, 255-S266. doi:10.1016/j.bulcan.2016.09.003 |
LECHANTEUR, C., BRIQUET, A., GIET, O., DELLOYE, O., BAUDOUX, E., & BEGUIN, Y. (2016). Clinical - scale expansion of mesenchymal stromal cells: a large banking experience. Journal of Translational Medicine, 14, 145-159. doi:10.1186/s12967-016-0892-y |
Mamez, Levy, V., Chevallier, P., Blaise, D., Vigouroux, S., Xhaard, A., Fegueux, N., Contentin, N., BEGUIN, Y., Ifrah, N., Bulabois, C., Suarez, F., Yakoub-Agha, I., Turlure, P., Deconink, E., Lamy, T., Cahn, J.-Y., Huynh, A., Maury, S., ... Nguyen, S. (2016). Effet of immune modulation in relapsed peripheral T-cell lymphomas after allogeneic stem cell transplantation: a study by the Société Française de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC). Bone Marrow Transplantation, 51, 358-364. doi:10.1038/bmt.2015.280 |
Pirotte, M., GUIOT, J., BEGUIN, Y., & Louis, R. (2016). L'anémie dans la bronchopneumopathie chronique obstructive sévère: une comorbidité plus fréquente que l'on ne croit. Revue Médicale de Liège, 71 (11), 488-494. |
SERVAIS, S., GREGOIRE, C., BARON, F., WILLEMS, E., BRIQUET, A., BAUDOUX, E., DELLOYE, O., GIET, O., LECHANTEUR, C., & BEGUIN, Y. (2016). Multipotent mesenchymal stromal cell therapy for steroid-refractory acute graft-versus-host disease after allogeneic stem cell transplantation. Belgian Journal of Hematology, 7, 229-235. |
HANNON, M., BEGUIN, Y., Ehx, G., SERVAIS, S., SEIDEL, L., Graux, C., Maertens, J., Kerre, T., Daulne, C., de Bock, M., Fillet, M., ORY, A., WILLEMS, E., GOTHOT, A., Humblet-Baron, S., & BARON, F. (15 July 2015). Immune Recovery after Allogeneic Hematopoietic Stem Cell Transplantation following Flu-TBI versus TLI-ATG Conditioning. Clinical Cancer Research, 21 (14), 3131-9. doi:10.1158/1078-0432.CCR-14-3374 |
Baron, F., Zachée, P., Maertens, J., Kerre, T., ORY, A., SEIDEL, L., Graux, C., Lewalle, P., Van Gelder, M., Theunissen, K., WILLEMS, E., Emonts, M.-P., De Becker, A., & Beguin, Y. (2015). Non-myeloablative allogeneic hematopoietic cell transplantation following fludarabine plus 2 Gy TBI or ATG plus 8 Gy TLI: a phase II randomized study from the Belgian Hematological Society. Journal of Hematology and Oncology, 8, 4. doi:10.1186/s13045-014-0098-9 |
Basak, G., Wiktor-Jedrzejczak, W., Labopin, M., Schoemans, H., Ljungman, P., Kobbe, G., Beguin, Y., Lang, P., Koenecke, C., Sykora, K., te Boome, L., van Biezen, A., van der Werf, S., Mohty, M., de Witte, T., Marsh, J., Dreger, P., Kröger, N., Duarte, R., & Ruutu, T. (2015). Allogeneic hematopoietic stem cell transplantation in solid organ transplant recipients: a retrospective, multicenter study of the EBMT. American Journal of Transplantation, 15, 705-714. doi:10.1111/ajt.13017 |
Beguin, Y., Selleslag, D., Meers, S., Graux, C., Bries, G., Deeren, D., Vrelust, I., Ravoet, C., Theunissen, K., Voelter, V., Potier, H., Trullemans, F., Noens, L., & Mineur, P. (2015). Safety and efficacy of azacitidine in Belgian patients with high-risk myelodysplastic syndromes, acute myeloid leukaemia, or chronic myelomonocytic leukaemia: results of a real-life, non-interventional post-marketing survey. Acta Clinica Belgica, 70, 34-43. doi:10.1179/2295333714Y.0000000102 |
Benghiat, F., Beguin, Y., Dessars, B., Devos, T., Lewalle, P., Mineur, P., Straetmans, N., Van Eygen, K., Verhoef, G., & Knoops, L. (2015). Practical management of Chronic Myeloid Leukemia in Belgium. Belgian Journal of Hematology, 6 (1), 16-32. |
BONNET, C., Janssens, A., Wu, K., Schroyens, W., Van Hende, V., Heimann, P., Tousseyn, T., André, M., Bron, D., Van Hoof, A., Verhoef, G., DE PRIJCK, B., Beguin, Y., & Dierickx, D. (2015). BHS guidelines for the treatment of Burkitt lymphoma. Belgian Journal of Hematology, 6 (2), 61-69. |
Bonnet, C., LEJEUNE, M., VAN KEMSEKE, C., Bron, D., & Beguin, Y. (2015). Prise en charge actuelle du lymphome de la zone marginale. Revue Médicale Suisse, 11, 1549-1556. |
Devos, T., Zachée, P., Bron, D., Noens, L., Van Droogenbroeck, J., Mineur, P., Beguin, Y., Berneman, Z., Benghiat, F. S., Kentos, A., Chatelain, C., Demuynck, H., Lemmens, J., Van Eygen, K., Theunissen, K., Trullemans, F., Pierre, P., Pluymers, W., & Knoops, L. (2015). Myelofibrosis patients in Belgium: disease characteristics. Acta Clinica Belgica, 70 (2), 105-111. doi:10.1179/2295333714Y.0000000097 |
Ehx, G.* , Hannon, M.* , BEGUIN, Y., Humblet-Baron, S.* , & BARON, F.*. (2015). Validation of a multicolor staining to monitor phosphoSTAT5 levels in regulatory T-cell subsets. Oncotarget, 6, 43255-43266. doi:10.18632/oncotarget.6486 * These authors have contributed equally to this work. |
Gauthier, J., Damaj, G., Langlois, C., Robin, M., Michallet, M., Chevallier, P., Beguin, Y., N'guyen, S., Bories, P., Blaise, D., Cornillon, J., Clavert, A., Mohty, M., Huynh, A., Thiébaut-Bertrand, A., Vigouroux, S., Duhamel, A., & Yakoub-Agha, I. (2015). Contribution of Revised International Prognostic Scoring System Cytogenetics to Predict Outcome After Allogeneic Stem Cell Transplantation for Myelodysplastic Syndromes: A Study From the Société Française de Greffe de Moelle et Thérapies Cellulaires. Transplantation, 99 (8), 1672-1680. |
Guillaume, T., Beguin, Y., Tabrizi, R., Nguyen, S., Blaise, D., Deconinck, E., Redjoul, R., Cornillon, J., Guillerm, G., Contentin, N., Sirvent, A., Turlure, P., Salmon, A., Huynh, A., Francois, S., Peffault de Latour, R., Yakoub-Agha, I., & Mohty, M. (2015). Allogeneic hematopoietic stem cell transplantation for T-prolymphocytic leukemia: a report from the French society for stem cell transplantation (SFGM-TC). European Journal of Haematology, 94, 265-269. doi:10.1111/ejh.12430 |
Halter, J., Michael, W., Schüpbach, W., Mandel, H., Casali, C., Orchard, K., Collin, M., Valcarcel, D., Rovelli, A., Filosto, M., Dotti, M., Marotta, G., Pintos, G., Barba, P., Accarino, A., Ferra, C., Illa, I., Beguin, Y., Bakker, J., ... Hirano, M. (2015). Allogeneic haematopoietic stem cell transplantation for mitochondrial neurogastrointestinal encephalomyopathy. Brain: a Journal of Neurology, 138, 2847-2858. doi:10.1093/brain/awv226 |
Leclerc, M., Suarez, F., Noël, M.-P., Vekhoff, A., Troussard, X., Claisse, J.-F., Thieblemont, C., Maloisel, F., Beguin, Y., Tamburini, J., Barbe, C., & Delmer, A. (2015). Rituximab therapy for hairy cell leukemia : a retrospective study of 41 cases. Annals of Hematology, 94, 89-95. doi:10.1007/s00277-014-2175-0 |
Rowart, P., ERPICUM, P., Detry, O., WEEKERS, L., Grégoire, C., LECHANTEUR, C., BRIQUET, A., Beguin, Y., Krzesinski, J.-M., & Jouret, F. (2015). Mesenchymal Stromal Cell Therapy in Ischemia/Reperfusion Injury. Journal of Immunology Research, 602597. doi:10.1155/2015/602597 |
SERVAIS, S., Menten-Dedoyart, C., Beguin, Y., SEIDEL, L., Gothot, A., Daulne, C., WILLEMS, E., Delens, L., Humblet-Baron, S., Hannon, M., & Baron, F. (2015). Impact of Pre-Transplant Anti-T Cell Globulin (ATG) on Immune Recovery after Myeloablative Allogeneic Peripheral Blood Stem Cell Transplantation. PLoS ONE, 10 (6), 0130026. doi:10.1371/journal.pone.0130026 |
SID, S., Dugauquier, C., DE PRIJCK, B., BONNET, C., & Beguin, Y. (2015). Haemolytic crisis induced by rasburicase administration revealing G-6-PD deficiency. Belgian Journal of Hematology, 6 (2), 74-78. |
DETRY, O., JOURET, F., VANDERMEULEN, M., ERPICUM, P., Delens, L., GREGOIRE, C., BRIQUET, A., WEEKERS, L., BAUDOUX, E., LECHANTEUR, C., & BEGUIN, Y. (December 2014). Cellules stromales mésenchymateuses et transplantation d'organes. Revue Médicale de Liège, 69, 53-56. |
Hannon, M., LECHANTEUR, C., Lucas, S., Somja, J., Seidel, L., Belle, L., Bruck, F., BAUDOUX, E., GIET, O., Chantillon, A.-M., Delvenne, P., Drion, P., Beguin, Y., Humblet-Baron, S., & Baron, F. (17 June 2014). Infusion of clinical-grade enriched regulatory T cells delays experimental xenogeneic graft-versus-host disease. Transfusion, 54 (February), 353-363. doi:10.1111/trf.12279 |
CAERS, J., HAFRAOUI, K., KEUTGENS, A., CABERG, J.-H., LAMBERT, F., TASSIN, F., & BEGUIN, Y. (02 February 2014). Haematological and molecular responses in refractory anaemia with ring sideroblasts and thrombocytosis treated with lenalidomide. European Journal of Haematology, 92 (2), 179-180. doi:10.1111/ejh.12233 |
Baron, F., Humblet-Baron, S., Ehx, G., SERVAIS, S., HANNON, M., Belle, L., LECHANTEUR, C., BRIQUET, A., GIET, O., BAUDOUX, E., WILLEMS, E., & Beguin, Y. (2014). Thinking out of the box - New approaches to controlling GVHD. Current Hematologic Malignancy Reports, 9, 73-84. doi:10.1007/s11899-013-0187-9 |
Battisti, O., & Beguin, Y. (2014). A propos de l'encéphalopathie du nouveau-né. Percentile, 19, 8-9. |
Beguin, Y., Aapro, M. S., Ludwig, H. P., Mizzen, L., & Osterborg, A. C. (2014). Epidemiological and nonclinical studies investigating effects of iron in carcinogenesis-A critical review. Critical Reviews in Oncology/Hematology, 89, 1-15. doi:10.1016/j.critrevonc.2013.10.008 |
Beguin, Y., & JASPERS, A. (2014). Iron sucrose - characteristics, efficacy and regulatory aspects of an established treatment of iron deficiency and iron-deficiency anemia in a broad range of therapeutic areas. Expert Opinion on Pharmacotherapy, 15, 2087-2103. doi:10.1517/14656566.2014.953928 |
Belaiche, S., Yafour, N., Balcaen, S., Beguin, Y., Borel, C., Bruno, B., Godin, S., Labussière-Wallet, H., Sanhamut, N., Charbonnier, A., de Berranger, E., Konopacki-Potet, J., Turlure, P., & Yakoub-Agha, I. (2014). Immunosuppresseurs dans la prévention de la réaction du greffon contre l'hôte : rapport de la SFGM-TC. Pathologie Biologie, 62, 197-203. doi:10.1016/j.patbio.2014.05.010 |
Binsfeld, M., Beguin, Y., Belle, L., Otjacques, E., HANNON, M., BRIQUET, A., Heusschen, R., Drion, P., Zilberberg, J., Bogen, B., Baron, F., & CAERS, J. (2014). Establishment of a murine graft-versus-myeloma model using allogeneic stem cell transplantation. PLoS ONE, 113764. doi:10.1371/journal.pone.0113764 |
Binsfeld, M., Fostier, K., Muller, J., Baron, F., Schots, R., Beguin, Y., Heusschen, R., & CAERS, J. (2014). Cellular immunotherapy in multiple myeloma : lessons from preclinical models. Biochimica et Biophysica Acta - Reviews on Cancer, 1846, 392-404. doi:10.1016/j.bbcan.2014.08.001 |
CAERS, J., & BEGUIN, Y. (2014). Le myélome multiple asymptomatique : le paysage thérapeutique change. Oncol. Hematol, 8, 39-45. |
CAERS, J., Binsfeld, M., Muller, J., Heusschen, R., & Beguin, Y. (2014). Gammapathie monoclonale de signification indéterminée : information destinée aux médecins référents. Revue Médicale de Liège, 69, 41-46. |
Chevallier, P., Labopin, M., Milpied, N., Bilger, K., Socié, G., Yakoub-Agha, I., Michallet, M., Bulabois, C.-E., Maury, S., Beguin, Y., Bay, J.-O., Blaise, D., Maillard, N., Guillerm, G., Daguindeau, E., Raus, N., & Mohty, M. (2014). Outcomes of adults with active or progressive hematological malignancies at time of allogeneic stem cell transplantation : a survey from the Société Française de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC). Bone Marrow Transplantation, 49, 361-365. |
Damaj, G., Mohty, M., Robin, M., Michallet, M., Chevallier, P., Beguin, Y., Nguyen, S., Bories, P., Blaise, D., Maillard, N., Rubio, M.-T., Fegueux, N., Cornillon, J., Clavert, A., Huynh, A., Adès, L., Thiébaut-Bertrand, A., Hermine, O., Vigouroux, S., ... Yakoub-Agha, I. (2014). Upfront allogeneic stem cell transplantation after reduced-intensity/nonmyeloablative conditioning for patients with myelodysplastic syndrome : a study by the Société Française de Greffe de Moelle et de Thérapie Cellulaire. Biology of Blood and Marrow Transplantation, 20, 1349-1355. doi:10.1016/j.bbmt.2014.05.010 |
Delforge, M., Selleslag, D., BEGUIN, Y., Triffet, A., Mineur, P., Theunissen, K., Graux, C., Trullemans, F., Boulet, D., Van Eygen, K., Noens, L., Van Steenweghen, S., Lemmens, J., Pierre, P., D'Hondt, R., Ferrant, A., Deeren, D., Van de Velde, A., Wynendaeke, W., ... Ravoet, C. (2014). Adequate iron chelation therapy for at least six months improves survival in transfusion-dependent patients wih lower risk myelodysplastic syndromes. Leukemia Research, 38, 557-563. |
Duléry, R., Mohty, M., Duhamel, A., Robin, M., BEGUIN, Y., Michallet, M., Vigouroux, S., Lioure, B., Garnier, A., El Cheikh, J., Bulabois, C.-E., Huynh, A., Bay, J.-O., Daguindau, E., Ceballos, P., Clément, L., Dauriac, C., Maillard, N., Legrand, F., ... Yakoub-Agha, I. (2014). Antithymocyte globulin before allogeneic stem cell transplantation for progressive myelodysplastic syndrome : a study from the French Society of Bone Marrow Transplantation and Cellular Therapy. Biology of Blood and Marrow Transplantation, 20, 646-654. doi:10.1016/j.bbmt.2014.01.016 |
Erpicum, P., DETRY, O., WEEKERS, L., BONVOISIN, C., LECHANTEUR, C., BRIQUET, A., Beguin, Y., Krzesinski, J.-M., & Jouret, F. (2014). Mesenchymal stromal cell therapy in conditions of renal ischaemia/reperfusion. Nephrology Dialysis Transplantation, 29, 1487-1493. doi:10.1093/ndt/gft538 |
JASPERS, A., Baron, F., WILLEMS, E., HAFRAOUI, K., Vanstraelen, G., Bonnet, C., & Beguin, Y. (2014). Erythropoietin therapy after allogeneic hematopoietic cell transplantation : a prospective randomized trial. Blood, 124, 33-41. doi:10.1182/blood-2014-01-546333 |
LECHANTEUR, C., Baila, S., Janssen, M. E., GIET, O., BRIQUET, A., BAUDOUX, E., & Beguin, Y. (2014). Large-Scale Clinical Expansion of Mesenchymal Stem Cells in the GMP-Compliant, Closed Automated Quantum® Cell Expansion System: Comparison with Expansion in Traditional T-Flasks. Journal of Stem Cell Research and Therapy, 4 (8), 1000222. doi:10.4172/2157- 7633.1000222 |
Ludwig, H. P., Aapro, M. S., Bokemeyer, C., Glaspy, J. A., Hedenus, M., Littlewood, T. J., Osterborg, A. C., Rzychon, B., Mitchell, D., & BEGUIN, Y. (2014). A European patient record study on diagnosis and treatment of chemotherapy-induced anaemia. Supportive Care in Cancer, 22, 2197-2206. doi:10.1007/s00520-014-2189-0 |
MOERMANS, C., LECHANTEUR, C., BAUDOUX, E., GIET, O., HENKET, M., SEIDEL, L., LEJEUNE, M., WILLEMS, E., Baron, F., LOUIS, R., & BEGUIN, Y. (2014). Impact of cotransplantation of mesenchymal stem cells on lung function after unrelated allogeneic hematopoietic stem cell transplantation following non-myeloablative conditioning. Transplantation, 98 (3), 348-353. doi:10.1097/TP.0000000000000068 |
Moors, I., Schoemans, H., Callens, S., Beguin, Y., & Kerre, T. (2014). Vaccination guidelines in hematopoietic transplant patients : recommendations from the BHS Transplant Committee. Belgian Journal of Hematology, 6, 44-54. |
VANDERMEULEN, M., GREGOIRE, C., BRIQUET, A., LECHANTEUR, C., BEGUIN, Y., & DETRY, O. (2014). Rationale for the potential use of mesenchymal stromal cells in liver transplantation. World Journal of Gastroenterology, 20 (44), 16418-32. doi:10.3748/wjg.v20.i44.16418 |
Bruck, F.* , Belle, L.* , LECHANTEUR, C., de Leval, L., Hannon, M., DUBOIS, S., CASTERMANS, E., Humblet-Baron, S., Rahmouni, S., Beguin, Y., BRIQUET, A.* , & Baron, F.*. (March 2013). Impact of bone marrow-derived mesenchymal stromal cells on experimental xenogeneic graft-versus-host disease. Cytotherapy, 15 (3), 267-279. doi:10.1016/j.jcyt.2012.09.003 * These authors have contributed equally to this work. |
BEGUIN, Y., Maertens, J., DE PRIJCK, B., Schots, R., Seidel, L., BONNET, C., HAFRAOUI, K., WILLEMS, E., Vanstraelen, G., SERVAIS, S., JASPERS, A., FILLET, G., & BARON, F. (2013). Darbepoetin-alfa and intravenous iron administration after autologous hematopoietic stem cell transplantation : A prospective multicenter randomized trial. American Journal of Hematology, 88, 990-996. doi:10.1002/ajh.23552 |
COLLINS, P., Vijgen, S., DE PRIJCK, B., BLETARD, N., Beguin, Y., & Delvenne, P. (2013). Chimiothérapie, immunodépression et cancers secondaires : rapport d'un cas clinique. Revue Médicale de Liège, 67, 418-422. |
De Bock, M., Fillet, M., Hannon, M., Seidel, L., Merville, M.-P., Gothot, A., Beguin, Y., & Baron, F. (2013). Kinetics of IL-7 and IL-15 Levels after Allogeneic Peripheral Blood Stem Cell Transplantation following Nonmyeloablative Conditioning. PLoS ONE, 8 (2), 55876. doi:10.1371/journal.pone.0055876 |
HAFRAOUI, K., DE PRIJCK, B., & Beguin, Y. (2013). Leucémie myélomonocytaire chronique : diagnostic et thérapeutique. Revue Médicale Suisse, 9, 1512-1517. |
Janssens, A., Lambert, C., Bries, G., Bosly, A., Selleslag, D., & Beguin, Y. (2013). Primary immune thrombocytopenia in adults. Belgian Journal of Hematology, 4 (1), 2-11. |
Moermans, C., Poulet, C., HENKET, M., Bonnet, C., WILLEMS, E., Baron, F., Beguin, Y., & Louis, R. (2013). Lung function and airway inflammation monitoring after hematopoietic stem cell transplantation. Respiratory Medicine, 107, 2071-2080. doi:10.1016/j.rmed.2013.10.013 |
Otjacques, E., Binsfeld, M., Beguin, Y., Noël, A., Cataldo, D., & CAERS, J. (2013). Aspects biologiques de l'angiogenèse dans le myélome multiple. Oncohématologie, 7 (2), 6-12. |
Otjacques, E., Binsfeld, M., Rocks, N., Blacher, S., Vanderkerken, K., Noël, A., Beguin, Y., Cataldo, D., & CAERS, J. (2013). Mithramycin Exerts an Anti-Myeloma Effect and Displays Anti-Angiogenic Effects through Up-Regulation of Anti-Angiogenic Factors. PLoS ONE, 8 (5), 62818. doi:10.1371/journal.pone.0062818 |
Park, S., Labopin, M., Yakoub-Agha, I., Delaunay, J., Dhedin, N., Deconinck, E., Michallet, M., Robin, M., De Revel, T., Bernard, M., Vey, N., Lioure, B., Lapusan, S., Tabrizi, R., Bourhis, J.-H., Huynh, A., Beguin, Y., Socié, G., Dreyfus, F., ... Mohty, M. (2013). Allogeneic stem cell transplantation for chronic myelomonocytic leukemia : a report from the Société Française de Greffe de Moelle et de Thérapie Cellulaire. European Journal of Haematology, 90, 355-364. doi:10.1111/ejh.12073 |
SERVAIS, S., Beguin, Y., & Baron, F. (2013). Emerging drugs for prevention of graft failure after allogeneic hematopoietic stem cell transplantation. Expert Opinion on Emerging Drugs, 18 (2), 173-192. doi:10.1517/14728214.2013.798642 |
SERVAIS, S., WILLEMS, E., Beguin, Y., & Baron, F. (2013). Allogreffe de cellules souches hématopoïétiques chez le patient âgé : jusqu'à quel âge ? Revue Médicale de Liège, 68 (1), 38-43. |
Aapro, M. S., Osterborg, A. C., Gascon, P., Ludwig, H. P., & BEGUIN, Y. (2012). Prevalence and management of cancer-related anaemia, iron deficiency and the specific role of intravenous iron. Annals of Oncology, 23, 1954-62. |
Aapro, M. S., Österborg, A., Gascon, P., Ludwig, H., & Beguin, Y. (2012). Anaemia and cancer : oral or intravenous iron ? Therapeutics, 46-48. |
Belle, L., Bruck, F., FOGUENNE, J., GOTHOT, A., BEGUIN, Y., Baron, F., & Briquet, A. (2012). Imatinib and Nilotinib Inhibit Hematopoietic Progenitor Cell Growth, but Do Not Prevent Adhesion, Migration and Engraftment of Human Cord Blood CD34+ Cells. PLoS ONE, 7 (12), 52564. doi:10.1371/journal.pone.0052564 |
Bonnet, C., DE PRIJCK, B., LEJEUNE, M., FASSOTTE, M.-F., Van Den Neste, E., & Beguin, Y. (2012). Prise en charge du lymphome B diffus à grandes cellules en 2012. Revue Médicale Suisse, 8, 1582-90. |
Damaj, G., Duhamel, A., Robin, M., Beguin, Y., Michallet, M., Mohty, M., Vigouroux, S., Bories, P., Garnier, A., El Cheikh, J., Bulabois, C.-E., Huynh, A., Bay, J.-O., Legrand, F., Deconinck, E., Fegueux, N., Clement, L., Dauriac, C., Maillard, N., ... Yakoub-Agha, I. (2012). Impact of Azacitidine before allogeneic stem-cell transplantation for myelodysplastic syndromes : a study b the Société Française de Greffe de Moelle et de Thérapie-Cellulaire and the Groupe Francophone des Myélodysplasies. Journal of Clinical Oncology, 30, 4533-4540. doi:10.1200/JCO.2012.44.3499 |
FRUSCH, N., SERVAIS, S., DE PRIJCK, B., Corhay, J.-L., Beguin, Y., Louis, R., & DUYSINX, B. (2012). Spontaneous pneumomediastinum caused by bleomycin-induced pneumonitis. Acta Clinica Belgica, 67-68. doi:10.2143/ACB.67.5.2062693 |
Huybrechts, S., BEGUIN, Y., Bordon, V., DRESSE, M.-F., Dupont, S., Ferster, A., Laureys, G., Meyts, I., Renard, M., & Vermylen, C. (2012). Less veno-occlusive disease after intravenous versus oral busulfan for autologous haematopoietic stem cell transp.l antation: the Belgian paediatric experlence. Belgian Journal of Hematology, 3 (2), 34-40. |
Malaise, O., FRUSCH, N., BECK, E., Servais, S., BETEA, D., CAERS, J., DE PRIJCK, B., & BEGUIN, Y. (2012). Panhypopituitarism and diabetus insipidus in a patient with primary central nervous system lymphoma. Leukemia and Lymphoma, 53 (12), 2515-16. |
Roelants, V., DELGAUDINE, M., Walrand, S., Lhommel, R., Beguin, Y., Jamar, F., & Vanoverschelde, J.-L. (2012). Myocardial infarct size quantification in mice by SPECT using a novel algorithm independent of a normal perfusion database. EJNMMI Research, 2, 64-75. doi:10.1186/2191-219X-2-64 |
VANDAMME, A., Schots, R., & BEGUIN, Y. (2012). Academic clinical trials run by the transplant committee of the Belgian Hematological Society. Belgian Journal of Hematology, 3 (2), 62-67. |
Verbeke, N., Beguin, Y., Wildiers, H., Canon, J.-L., Bries, G., Bosly, A., & Van Belle, S. (2012). High prevalence of anaemia and limited use of therapy in cancer patients : a Belgian survey (Anaemia Day 2008). Supportive Care in Cancer, 20, 23-28. doi:10.1007/s00520-010-1045-0 |
VERTENOEIL, G., SERVAIS, S., & Beguin, Y. (2012). Comment j'explore... une fièvre d'origine indéterminée chez le patient adulte ? Revue Médicale de Liège, 67 (7-8), 391-397. |
Zeddou, M., RELIC, B., MALAISE, O., CHARLIER, E., Desouroux, A., BEGUIN, Y., DE SENY, D., & Malaise, M. (2012). Differential signalling through ALK-1 and ALK-5 regulates leptin expression in Mesenchymal Stem Cells. Stem Cells and Development, 21 (11), 1948-54. doi:10.1089/scd.2011.0321 |
Noterdaeme, T., Longree, L., Bataille, C., DE ROOVER, A., LAMPROYE, A., DELWAIDE, J., Beguin, Y., Honoré, P., & DETRY, O. (July 2011). Liver transplantation for acute hepatic failure due to chemotherapy-induced HBV reactivation in lymphoma patients. World Journal of Gastroenterology, 17 (25), 3069-72. doi:10.3748/wjg.v17.i25.3069 |
Aapro, M. S., Beguin, Y., Birgegard, G., Gascon, P., Hedenus, M., & Osterborg, A. (2011). Too low iron doses and too many dropouts in negative iron trial. Journal of Clinical Oncology, 525-e526. doi:10.1200/JCO.2011.35.3219 |
Bonnet, C., CAERS, J., DE PRIJCK, B., HAFRAOUI, K., & Beguin, Y. (2011). Lymphome du manteau : prise en charge 2011. Revue Médicale Suisse, 7, 1644-1649. |
CAERS, J., BONNET, C., GRAUX, C., DE PRIJCK, B., & BEGUIN, Y. (2011). Prise en charge actuelle des syndromes myélodysplasiques. Revue Médicale Suisse, 7, 1634-1643. |
CASTERMANS, E., Hannon, M., Dutrieux, J., Humblet, S., Seidel, L., Cheynier, R., Willems, E., Gothot, A., Vanbellinghen, J.-F., Geenen, V., Sandmaier, B. M., Storb, R., Beguin, Y., & Baron, F. (2011). Thymic recovery after allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning is limited to patients younger than 60 years of age. Haematologica, 96(2), 298-306. doi:10.3324/haematol.2010.029702 |
DELGAUDINE, M., Lambermont, B., Lancellotti, P., Roelants, V., Walrand, S., Vanoverschelde, J.-L., Pierard, L., Gothot, A., & Beguin, Y. (2011). Effects of granulocyte-colony-stimulating factor on progenitor cell mobilization and heart perfusion and function in normal mice. Cytotherapy, 13, 237-247. doi:10.3109/14653249.2010.491820 |
Robin, M., Sanz, G. F., Ionescu, I., Rio, B., Sirvent, A., Renaud, M., Carreras, E., Milpied, N., Mohty, M., Beguin, Y., Bordigoni, P., De Witte, T., Picardi, A., Purtill, D., Gluckman, E., Kroger, N., & Rocha, V. (2011). Unrelated cord blood transplantation in adults with myelodysplasia or secondary acute myeloblastic leukemia : a survey on behalf of Eurocord and CLWP of EBMT. Leukemia, 25, 75-81. doi:10.1038/leu.2010.219 |
SERVAIS, S., Baron, F., & Beguin, Y. (2011). Allogeneic hematopoietic stem cell transplantation (HSCT) after reduced intensity conditioning. Transfusion and Apheresis Science, 44, 205-210. doi:10.1016/j.transci.2011.01.019 |
Servais, S., Beguin, Y., & Baron, F. (2011). Reduced intensity conditioning for allogeneic hematopoietic stem cell transplantation (HSCT). Belgian Journal of Hematology, 2, 3-9. |
Baron, F., & Beguin, Y. (2010). Hematopoietic stem cell transplantation in the treatment strategy of acute leukemia. Belgian Journal of Medical Oncology, 4, 118-123. |
Briquet, A., Dubois, S., Bekaert, S., Dolhet, M., Beguin, Y., & Gothot, A. (2010). Prolonged ex vivo culture of human bone marrow mesenchymal stem cells influences their supportive activity toward NOD/SCID -repopulating cells and committed progenitor cells of B lymphoid and myeloid lineages. Haematologica, 95 (1), 47-56. doi:10.3324/haematol.2009.008524 |
Dirix, L., Awada, A., Bron, D., Canon, J.-L., De Grève, J., Humblet, Y., Peeters, M., Van Belle, S., Vansteenkiste, J., Beguin, Y., & Vermorken, J. (2010). Practice guidelines on the use of erythropoiesis-stimulating agents in the treatment of chemotherapy-induced anemia. Belgian Journal of Medical Oncology, 4, 57-64. |
Jaspers, A., Baron, F., Bonnet, C., De Prijck, B., Fassotte, M.-F., & Beguin, Y. (2010). Le lymphome du manteau. Revue Médicale de Liège, 65, 171-176. |
Roufosse, R., & Beguin, Y. (2010). Observance thérapeutique en hématologie : le cas particulier de la leucémie myéloïde chronique. Revue Médicale de Liège, 65, 409-412. |
Servais, S., Caers, J., Warling, O., Frusch, N., Baron, F., De Prijck, B., & Beguin, Y. (2010). Enteroviral meningoencephalitis as complication of Rituximab therapy in a patient treated for diffuse large B-cell lymphoma. British Journal of Haematology, 150 (3), 379-381. doi:10.1111/j.1365-2141.2010.08202.x |
Servais, S., Willems, E., Beguin, Y., & Baron, F. (2010). Maladie du greffon contre l'hôte chronique : une prise en charge multidisciplinaire. Revue Médicale de Liège, 65, 81-87. |
Willems, E.* , Baron, F.* , Seidel, L., Frère, P., Fillet, G., & Beguin, Y. (2010). Comparison of thrombotic microangiopathy after allogeneic hematopoietic cell transplantation with high-dose or nonmyeloablative conditioning. Bone Marrow Transplantation, 45, 689-693. doi:10.1038/bmt.2009.230 * These authors have contributed equally to this work. |
Willems, E., Humblet-Baron, S., Dengis, O., Seidel, L., Beguin, Y., & Baron, F. (2010). Elevations of tumor necrosis factor-receptor-1 at day 7 and acute graft-versus-host disease after allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning. Bone Marrow Transplantation, 45, 1442-1448. doi:10.1038/bmt.2009.360 |
Avivi, I., Montoto, S., Canals, C., Maertens, J., Al-Ali, H., Mufti, G. J., Finke, J., Schattenberg, A., Fanin, R., Cornelissen, J. J., Vernant, J.-P., Russel, N., Beguin, Y., Thomason, K., Verdonck, L. F., Kobbe, G., Tilly, H., Socié, G., & Sureda, A. (2009). Matched unrelated donor stem cell transplant in 131 patients with follicular lymphoma : an analysis from the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation. British Journal of Haematology, 147, 719-728. doi:10.1111/j.1365-2141.2009.07905.x |
Beguin, Y. (2009). Utilisation thérapeutique de l'érythropoïétine. Revue du Praticien, 59, 82-83. |
Bonnet, C., Beguin, Y., De Prijck, B., de Leval, L., & Fillet, G. (2009). Traitements actuels du lymphome folliculaire. Revue Médicale Suisse, 5, 1663-7. |
Bonnet, C., Beguin, Y., De Prijck, B., Witvrouw, N., Hustinx, R., & Fillet, G. (2009). Les anticorps monoclonaux en hématologie en 2009. Revue Médicale de Liège, 64, 268-273. |
Castermans, E., Hannon, M., Drion, P., Geenen, V., Beguin, Y., & Baron, F. (2009). Reconstitution du système immunitaire après allogreffe de cellules souches hématopoïétiques. Revue Médicale de Liège, 64 (S1), 2-8. |
Dugauquier, C., Bataille, Y., Willems, E., Frere, P., De Prijck, B., Beguin, Y., & Baron, F. (2009). Toxoplasmore cérébrale compliquant une mini-allogreffe de cellules souches hématopoïétiques du sang périphérique. Revue Médicale de Liège, 64 (7-8), 366-369. |
Foguenne, J., Di Stefano, Giet, O., Beguin, Y., & Gothot, A. (2009). Ex vivo expansion of hematopoietic progenitor cells is associated with downregulation of alpha4 integrin- and CXCR4-mediated engraftment in NOD/SCID beta2-microglobulin-null mice. Haematologica, 94, 185-194. doi:10.3324/haematol.13206 |
Hafraoui, K., Beguin, Y., & Baron, F. (2009). Cancers secondaires après allogreffe de cellules souches hématopoïétiques. Revue Médicale de Liège, 64 (10), 496-499. |
Morrhaye, G., Kermani, H., Legros, J.-J., Baron, F., Beguin, Y., Moutschen, M., Cheynier, R., Martens, H., & Geenen, V. (2009). Impact of growth hormone (GH) deficiency and GH replacement upon thymus function in adult patients. PLoS ONE, 4 (5), 5668. doi:10.1371/journal.pone.0005668 |
Relic, B., Zeddou, M., Desoroux, A., Beguin, Y., De Seny, D., & Malaise, M. (2009). Genistein induces adipogenesis but inhibits leptin induction in human synovial fibroblasts. Laboratory Investigation, 89 (7), 811-822. doi:10.1038/labinvest.2009.41 |
Willems, E.* , Baron, F.* , Baudoux, E., Wanten, N., Seidel, L., Vanbellinghen, J.-F., Herens, C., Gothot, A., Frere, P., Bonnet, C., Hafraoui, K., Vanstraelen, G., Fillet, G., & Beguin, Y. (2009). Non-myeloablative transplantation with CD8-depleted or unmanipulated peripheral blood stem cells: a phase II randomized trial. Leukemia, 23 (3), 608-10. doi:10.1038/leu.2008.248 * These authors have contributed equally to this work. |
Willems, E., Canivet, J.-L., Ghaye, B., de Leval, L., Radermecker, M., Preiser, J.-C., & Beguin, Y. (2009). Pulmonary veno-occlusive disease in myeloproliferative disorder. European Respiratory Journal, 33 (1), 213-216. doi:10.1183/09031936.00157707 |
Willemze, R., Rodrigues, C. A., Labopin, M., Sanz, G., Michel, G., Socié, G., Rio, B., Sirvent, A., Renaud, M., Madero, L., Mothy, M., Ribera, J. M., Garnier, F., Garcia, J., Lecchi, L., Kögler, G., Beguin, Y., Navarette, C., Boogaerts, M., ... Rocha, V. (2009). KIR-ligand incompatibility in the Graft-versus-host direction improves outcome after umbilical cord blood transplantation for acute leukemia. Leukemia, 23, 492-500. doi:10.1038/leu.2008.365 |
Beguin, Y. (2008). Le sang de cordon ombilical. Revue du Praticien, 58, 2107-08. |
Brand, A., Rebulla, P., Engelfriet, C. P., Reesink, H. W., Beguin, Y., Baudoux, E., Kögler, G., Ebrahimi, M., Grazzini, G., Costa, A. N., Bosi, A., Sacchi, S., Lombardini, L., Pupella, S., Lecchi, L., Calderon Garciduenas, E. D., van Beckhoven, J. M., de Wit, H. J. C., Fibbe, W. E., ... Regan, F. (2008). Cord blood banking. Vox Sanguinis, 95, 335-348. doi:10.1111/j.1423-0410.2008.01106.x |
Castermans, E.* , Baron, F.* , Willems, E., Schaaf-Lafontaine, N., Meuris, N., Gothot, A., Vanbellinghen, J.-F., Herens, C., Seidel, L., Geenen, V., Cheynier, R., & Beguin, Y. (2008). Evidence for neo-generation of T cells by the thymus after non-myeloablative conditioning. Haematologica, 93 (2), 240-7. doi:10.3324/haematol.11708 * These authors have contributed equally to this work. |
Hoyoux, C., Dresse, M.-F., Robinet, S., Forget, P., Pieltain, C., Ketelslegers, O., & Beguin, Y. (2008). Cord blood transplantation in a child with Pearson's disease. Pediatric Blood and Cancer, 51 (4), 566. doi:10.1002/pbc.21615 |
Lejeune, M., Beguin, Y., De Prijck, B., Fassotte, M.-F., Fillet, G., & Baron, F. (2008). Comment je traite...La leucémie myéloblastique aiguë (LMA) du sujet age en bon état général. Revue Médicale de Liège, 63 (2), 59-63. |
Bovy, C., Gothot, A., Krzesinski, J.-M., Warling, X., & Beguin, Y. (20 January 2007). Mature erythrocyte parameters as new markers of functional iron deficiency in haemodialysis: sensitivity and specificity. Nephrology Dialysis Transplantation, 11, 1156-1162. doi:10.1093/ndt/gfl765 |
Bonnet, C., Beguin, Y., Fassotte, M.-F., Seidel, L., Luyckx, F., & Fillet, G. (2007). Limited usefulness of CA125 measurement in the management of Hodgkin's and non-Hodgkin's lymphoma. European Journal of Haematology, 78 (5), 399-404. doi:10.1111/j.1600-0609.2007.00843.x |
Castermans, E., Morrhaye, G., Marchand, S., Martens, H., Moutschen, M., Baron, F., Beguin, Y., & Geenen, V. (2007). Evaluation clinique de la fonction du thymus. Revue Médicale de Liège, 62 (11), 675-8. |
Castermans, E., Morrhaye, G., Marchand, S., Martens, H., Moutschen, M., Geenen, V., Beguin, Y., & Baron, F. (2007). Evaluation de la thymopoiese: applications cliniques. Revue Médicale de Liège, 62 (12), 725-9. |
De Prijck, B., Baron, F., Beguin, Y., Bonnet, C., Willems, E., & Fillet, G. (2007). Actualités thérapeutiques en hématologie. Revue Médicale de Liège, 62 (5-6), 384-90. |
Baron, F., Vanstraelen, G., & Beguin, Y. (2006). Transfusions after nonmyeloablative or reduced-intensity conditioning regimens. Leukemia, 20 (12), 2081-6. doi:10.1038/sj.leu.2404431 |
Bovy, C., Baudoux, E., Salmon, J., & Beguin, Y. (2006). Increased iron absorption during autologous blood donation supported by recombinant human erythropoietin therapy. Transfusion, 46 (9), 1616-23. doi:10.1111/j.1537-2995.2006.00945.x |
Cavill, I., Auerbach, M., Bailie, G. R., Barrett-Lee, P., Beguin, Y., Kaltwasser, P., Littlewood, T., Macdougall, I. C., & Wilson, K. (2006). Iron and the anaemia of chronic disease: a review and strategic recommendations. Current Medical Research and Opinion, 22 (4), 731-7. doi:10.1185/030079906X100096 |
Frere, P., Baron, F., Bonnet, C., Hafraoui, K., Pereira-Martins, M., Willems, E., Fillet, G., & Beguin, Y. (2006). Infections after allogeneic hematopoietic stem cell transplantation with a nonmyeloablative conditioning regimen. Bone Marrow Transplantation, 37 (4), 411-8. doi:10.1038/sj.bmt.1705255 |
Frere, P., Pereira-Martins, M., Fillet, G., & Beguin, Y. (2006). Infections after CD34-selected or unmanipulated autologous hematopoietic stem cell transplantation. European Journal of Haematology, 76 (2), 102-8. doi:10.1111/j.1600-0609.2005.00569.x |
Pirson, L.* , Baron, F.* , Meuris, N., Giet, O., Castermans, E., Greimers, R., Di Stefano, I., Gothot, A., & Beguin, Y. (2006). Despite inhibition of hematopoietic progenitor cell growth in vitro, the tyrosine kinase inhibitor imatinib does not impair engraftment of human CD133+ cells into NOD/SCIDbeta2mNull mice. Stem Cells, 24 (7), 1814-21. doi:10.1634/stemcells.2005-0290 * These authors have contributed equally to this work. |
Van Overstraeten-Schlogel, N., Beguin, Y., & Gothot, A. (2006). Role of stromal-derived factor-1 in the hematopoietic-supporting activity of human mesenchymal stem cells. European Journal of Haematology, 76 (6), 488-93. doi:10.1111/j.1600-0609.2006.00633.x |
Van Overstraeten-Schlogel, N., Delgaudine, M., Beguin, Y., & Gothot, A. (2006). Limitations of the use of GFP transgenic mice in bone marrow transplantation studies. Leukemia and Lymphoma, 47 (7), 1392-3. doi:10.1080/10428190500513512 |
Vanstraelen, G., Baron, F., Willems, E., Bonnet, C., Hafraoui, K., Frere, P., Fillet, G., & Beguin, Y. (2006). Recombinant human erythropoietin therapy after allogeneic hematopoietic cell transplantation with a nonmyeloablative conditioning regimen: low donor chimerism predicts for poor response. Experimental Hematology, 34 (7), 841-50. doi:10.1016/j.exphem.2006.04.012 |
Vanstraelen, G., Frere, P., Ngirabacu, M.-C., Willems, E., Fillet, G., & Beguin, Y. (2006). Pegfilgrastim compared with Filgrastim after autologous hematopoietic peripheral blood stem cell transplantation. Experimental Hematology, 34 (3), 382-8. doi:10.1016/j.exphem.2005.11.013 |
Bataille, Y., Bovy, C., Lancellotti, P., Melchior, V., Delbecque, K., Beguin, Y., & Krzesinski, J.-M. (2005). Primary amyloidosis (AL) as a cause of nephrotic syndrome. Acta Clinica Belgica, 60 (2), 94-7. doi:10.1179/acb.2005.017 |
Beguin, Y. (2005). Intravenous iron and recombinant human erythropoietin in cancer patients. Journal of Clinical Oncology, 23 (3), 651-2; author reply 652-3. doi:10.1200/JCO.2005.05.184 |
Bovy, C., Gothot, A., Krzesinski, J.-M., & Beguin, Y. (2005). Mature erythrocyte indices: new markers of iron availability. Haematologica, 90 (4), 549-51. |
Foguenne, J., Huygen, S., Greimers, R., Beguin, Y., & Gothot, A. (2005). Modulation of homing properties of primitive progenitor cells generated by ex vivo expansion. Haematologica, 90 (4), 445-51. |
Glaspy, J., & Beguin, Y. (2005). Anaemia management strategies: optimising treatment using epoetin beta (NeoRecormon). Oncology, 69 Suppl 2, 8-16. doi:10.1159/000088283 |
Piette, C., Dresse, M.-F., Forget, P., Schmitz, V., Demarche, M., Erpicum, P., Closon, M.-T., Rutten, I., Paulus, P., Vivegnis, D., Beguin, Y., Jamblin, P., & Hoyoux, C. (2005). Les neuroblastomes de l'enfant. A propos de 23 cas. Revue Médicale de Liège, 60 (3), 173-80. |
T'Sjoen, G., Beguin, Y., Feyen, E., Rubens, R., Kaufman, J.-M., & Gooren, L. (2005). Influence of exogenous oestrogen or (anti-) androgen administration on soluble transferrin receptor in human plasma. Journal of Endocrinology, 186 (1), 61-7. doi:10.1677/joe.1.06112 |
Vanstraelen, G., Baron, F., Frere, P., Hafraoui, K., Fillet, G., & Beguin, Y. (2005). Efficacy of recombinant human erythropoietin therapy started one month after autologous peripheral blood stem cell transplantation. Haematologica, 90 (9), 1269-70. |
Willems, E., Baron, F., Vanstraelen, G., Frere, P., Fillet, G., & Beguin, Y. (2005). Immunotherapie du cancer par minigreffe de cellules souches hematopoietiques. Revue Médicale Suisse, 1 (30), 1973-7. |
Beguin, Y., & Weber, G. (2004). Serum selenium in lymphoma. Journal of Clinical Oncology, 22 (16), 3429; author reply 3430. doi:10.1200/JCO.2004.99.240 |
Bovy, C., Krzesinski, J.-M., Gothot, A., & Beguin, Y. (2004). Impact of erythropoietic activity on red cell parameters in chronic renal failure patients. Haematologica, 89 (6), 748-9. |
Frere, P., Hermanne, J.-P., Debouge, M.-H., De Mol, P., Fillet, G., & Beguin, Y. (2004). Bacteremia after hematopoietic stem cell transplantation: incidence and predictive value of surveillance cultures. Bone Marrow Transplantation, 33 (7), 745-9. doi:10.1038/sj.bmt.1704414 |
Passweg, J. R., Rabusin, M., Musso, M., Beguin, Y., Cesaro, S., Ehninger, G., Espigado, I., Iriondo, A., Jost, L., Koza, V., Lenhoff, S., Lisukov, I., Locatelli, F., Marmont, A., Philippe, Pilatrino, C., Quartier, P., Stary, J., Veys, P., ... Gratwohl, A. (2004). Haematopoetic stem cell transplantation for refractory autoimmune cytopenia. British Journal of Haematology, 125 (6), 749-55. doi:10.1111/j.1365-2141.2004.04978.x |
Baron, F., Baudoux, E., Frere, P., Tourqui, S., Schaaf-Lafontaine, N., Herens, C., De Prijck, B., Fillet, G., & Beguin, Y. (2003). Low T-cell chimerism is not followed by graft rejection after nonmyeloablative stem cell transplantation (NMSCT) with CD34-selected PBSC. Bone Marrow Transplantation, 32 (8), 829-34. doi:10.1038/sj.bmt.1704220 |
Baron, F., DRESSE, M.-F., & Beguin, Y. (2003). Transmission of chronic myeloid leukemia through peripheral-blood stem-cell transplantation. New England Journal of Medicine, 349 (9), 913-4. doi:10.1056/NEJM200308283490921 |
Baron, F., Frere, P., Baudoux, E., Sautois, B., Fillet, G., & Beguin, Y. (2003). Non-myeloablative stem cell transplantation with low-dose total body irradiation and fludarabine for metastatic renal cell carcinoma. Haematologica, 88 (4), 478-80. |
Baron, F., Frere, P., Baudoux, E., Schaaf-Lafontaine, N., Fillet, G., & Beguin, Y. (2003). Low incidence of acute graft-versus-host disease after non-myeloablative stem cell transplantation with CD8-depleted peripheral blood stem cells: an update. Haematologica, 88 (7), 835-7. |
Baron, F., Frere, P., & Beguin, Y. (2003). Once weekly recombinant human erythropoietin therapy is very efficient after allogeneic peripheral blood stem cell transplantation when started soon after engraftment. Haematologica, 88 (6), 718-20. |
Baron, F., Frere, P., Fillet, G., & Beguin, Y. (2003). Tandem high-dose therapy (HDT) for multiple myeloma: recombinant human erythropoietin therapy given between first and second HDT allows second peripheral blood stem cell transplantation without red blood cell transfusion. British Journal of Haematology, 123 (1), 103-5. doi:10.1046/j.1365-2141.2003.04556.x |
Baron, F., Frere, P., Fillet, G., & Beguin, Y. (2003). Recombinant human erythropoietin therapy is very effective after an autologous peripheral blood stem cell transplant when started soon after engraftment. Clinical Cancer Research, 9 (15), 5566-72. |
Baron, F., Schaaf-Lafontaine, N., Humblet-Baron, S., Meuris, N., Castermans, E., Baudoux, E., Frere, P., Bours, V., Fillet, G., & Beguin, Y. (2003). T-cell reconstitution after unmanipulated, CD8-depleted or CD34-selected nonmyeloablative peripheral blood stem-cell transplantation. Transplantation, 76 (12), 1705-13. doi:10.1097/01.TP.0000093987.11389.F7 |
Beguin, Y. (2003). Soluble transferrin receptor for the evaluation of erythropoiesis and iron status. Clinica Chimica Acta, 329 (1-2), 9-22. doi:10.1016/S0009-8981(03)00005-6 |
Beguin, Y., & Baron, F. (2003). Minitransplants: allogeneic stem cell transplantation with reduced toxicity. Acta Clinica Belgica, 58 (1), 37-45. doi:10.1179/acb.2003.58.1.005 |
Cazzola, M., Beguin, Y., Kloczko, J., Spicka, I., & Coiffier, B. (2003). Once-weekly epoetin beta is highly effective in treating anaemic patients with lymphoproliferative malignancy and defective endogenous erythropoietin production. British Journal of Haematology, 122 (3), 386-93. doi:10.1046/j.1365-2141.2003.04439.x |
Gothot, A., Giet, O., Huygen, S., & Beguin, Y. (2003). Binding and migration across fibronectin and VCAM-1 of cycling hematopoietic progenitor cells. Leukemia and Lymphoma, 44 (8), 1379-83. doi:10.1080/1042819031000083406 |
Hafraoui, K., Humblet-Baron, S., Baron, F., Beguin, Y., & Fillet, G. (2003). Comment je traite ... la leucemie myeloide chronique (LMC). Revue Médicale de Liège, 58 (1), 7-12. |
Humblet-Baron, S., Baron, F., Chachati, A., Bury, J., Morelon, E., Kreis, H., & BEGUIN, Y. (2003). Donor lymphocyte infusion for late relapse followed by kidney transplantation for end-stage renal failure after allogeneic bone marrow transplantation for chronic myeloid leukemia. Transplantation, 76 (10), 1531-2. doi:10.1097/01.TP.0000085285.59061.D7 |
Schetelig, J., Fetscher, S., Reichle, A., Berdel, W. E., Beguin, Y., Brunet, S., Caballero, D., Majolino, I., Hagberg, H., Johnsen, H. E., Kimby, E., Montserrat, E., Stewart, D., Copplestone, A., Rosler, W., Pavel, J., Kingreen, D., & Siegert, W. (2003). Long-term disease-free survival in patients with angioimmunoblastic T-cell lymphoma after high-dose chemotherapy and autologous stem cell transplantation. Haematologica, 88 (11), 1272-8. |
Baron, F., Baudoux, E., Fillet, G., & Beguin, Y. (2002). Retrospective comparison of CD34-selected allogeneic peripheral blood stem cell transplantation followed by CD8-depleted donor lymphocyte infusions with unmanipulated bone marrow transplantation. Hematology, 7 (3), 137-43. doi:10.1080/1024533021000008173 |
Baron, F., Baudoux, E., Frere, P., Tourqui, S., Schaaf-Lafontaine, N., Greimers, R., Herens, C., Fillet, G., & Beguin, Y. (2002). Nonmyeloablative stem cell transplantation with CD8-depleted or CD34-selected peripheral blood stem cells. Journal of Hematotherapy and Stem Cell Research, 11 (2), 301-14. doi:10.1089/152581602753658484 |
Baron, F., & Beguin, Y. (2002). Preemptive cellular immunotherapy after T-cell-depleted allogeneic hematopoietic stem cell transplantation. Biology of Blood and Marrow Transplantation, 8 (7), 351-9. doi:10.1053/bbmt.2002.v8.pm12171481 |
Baron, F., & Beguin, Y. (2002). Nonmyeloablative allogeneic hematopoietic stem cell transplantation. Journal of Hematotherapy and Stem Cell Research, 11 (2), 243-63. doi:10.1089/152581602753658448 |
Baron, F., Fillet, G., & Beguin, Y. (2002). Erythropoiesis after nonmyeloablative stem-cell transplantation is not impaired by inadequate erythropoietin production as observed after conventional allogeneic transplantation. Transplantation, 74 (12), 1692-6. doi:10.1097/00007890-200212270-00008 |
Baron, F., Frere, P., Herens, C., Fillet, G., & Beguin, Y. (2002). Combination of nonmyeloablative stem cell transplantation and Imatinib in accelerated phase CML. Haematologica, 87 (12), 43. |
Baron, F., Sautois, B., Baudoux, E., Matus, G., Fillet, G., & Beguin, Y. (2002). Optimization of recombinant human erythropoietin therapy after allogeneic hematopoietic stem cell transplantation. Experimental Hematology, 30 (6), 546-54. doi:10.1016/S0301-472X(02)00795-6 |
Baron, F., Siquet, J., Schaaf-Lafontaine, N., Baudoux, E., Hermanne, J.-P., Fillet, G., & Beguin, Y. (2002). Pre-emptive immunotherapy with CD8-depleted donor lymphocytes after CD34-selected allogeneic peripheral blood stem cell transplantation. Haematologica, 87 (1), 78-88. |
Beguin, Y. (2002). Prediction of response and other improvements on the limitations of recombinant human erythropoietin therapy in anemic cancer patients. Haematologica, 87 (11), 1209-21. |
Beguin, Y. (2002). Le métabolisme du fer. Hématologie, 8, 7-S11. |
Beguin, Y., Benoit, Y., Crokaert, F., Selleslag, D., & Vandercam, B. (2002). Outpatient and home parenteral antibiotic therapy (OHPAT) in low-risk febrile neutropenia: consensus statement of a Belgian panel. Acta Clinica Belgica, 57 (6), 309-16. doi:10.1179/acb.2002.058 |
Engelfriet, C. P., Reesink, H. W., Wagner, J. E., Kogler, G., Rocha, V., Wernet, P., Lecchi, L., Lazzari, L., Ratti, I., Giovanelli, S., Poli, F., Rebulla, P., Beguin, Y., Baudoux, E., Navarrete, C., Armitage, S., Laughlin, M. J., & McClelland, W. M. (2002). International forum. Use of umbilical cord blood progenitor cells as an alternative for bone marrow transplantation. Vox Sanguinis, 83 (2), 172-87. doi:10.1046/j.1423-0410.2002.00197.x |
Frere, P., Hermanne, J.-P., Debouge, M.-H., Fillet, G., & Beguin, Y. (2002). Changing pattern of bacterial susceptibility to antibiotics in hematopoietic stem cell transplant recipients. Bone Marrow Transplantation, 29 (7), 589-94. doi:10.1038/sj/bmt/1703413 |
Giet, O., Van Bockstaele, D. R., Di Stefano, I., Huygen, S., Greimers, R., Beguin, Y., & Gothot, A. (2002). Increased binding and defective migration across fibronectin of cycling hematopoietic progenitor cells. Blood, 99 (6), 2023-31. doi:10.1182/blood.V99.6.2023 |
Gothot, A., Giet, O., Huygen, S., & Beguin, Y. (2002). Modulation par le cycle cellulaire de l'implantation des cellules souches hématopoïétiques. Hématologie, 8, 397-404. |
Huygen, S., Giet, O., Artisien, V., Di Stefano, I., Beguin, Y., & Gothot, A. (2002). Adhesion of synchronized human hematopoietic progenitor cells to fibronectin and vascular cell adhesion molecule-1 fluctuates reversibly during cell cycle transit in ex vivo culture. Blood, 100 (8), 2744-52. doi:10.1182/blood.V100.8.2744 |
Verhoef, H., West, C. E., Veenemans, J., Beguin, Y., & Kok, F. J. (2002). Stunting may determine the severity of malaria-associated anemia in African children. Pediatrics, 110 (4), 48. doi:10.1542/peds.110.4.e48 |
Warland, V., Jerusalem, G., Hustinx, R., Beguin, Y., Silvestre, R. M., Fassotte, M.-F., Foidart, J., & Fillet, G. (2002). Comment etablir le bilan de fin de traitement des patients atteints de lymphomes non-hodgkiniens (LNH) de malignite intermediaire ou elevee? Revue Médicale de Liège, 57 (12), 779-84. |
Baron, F., Frere, P., Fillet, G., & Beguin, Y. (2001). Treatment of leukemia relapse after allogeneic hematopoietic stem cell transplantation by donor lymphocyte infusion and STI-571. Haematologica, 86 (9), 993-4. |
Beguin, Y. (2001). Intérêt du dosage du récepteur soluble de la transferrine (sTfR) pour l'évaluation de l'érythropoïèse et de l'état du fer. Hématologie, 7, 161-169. |
Fillet, G., & Beguin, Y. (2001). Monitoring of erythropoiesis by the serum transferrin receptor and erythropoietin. Acta Clinica Belgica, 56 (3), 146-54. doi:10.1179/acb.2001.024 |
Giet, O., Huygen, S., Beguin, Y., & Gothot, A. (2001). Cell cycle activation of hematopoietic progenitor cells increases very late antigen-5-mediated adhesion to fibronectin. Experimental Hematology, 29 (4), 515-24. doi:10.1016/S0301-472X(00)00682-2 |
Piron, M., Loo, M., Gothot, A., Tassin, F., Fillet, G., & Beguin, Y. (2001). Cessation of intensive treatment with recombinant human erythropoietin is followed by secondary anemia. Blood, 97 (2), 442-8. doi:10.1182/blood.V97.2.442 |
R'Zik, S., & Beguin, Y. (2001). Serum soluble transferrin receptor concentration is an accurate estimate of the mass of tissue receptors. Experimental Hematology, 29 (6), 677-85. doi:10.1016/S0301-472X(01)00641-5 |
R'Zik, S., Loo, M., & Beguin, Y. (2001). Reticulocyte transferrin receptor (TfR) expression and contribution to soluble TfR levels. Haematologica, 86 (3), 244-51. |
Sautois, B., Baudoux, E., Salmon, J., Michaux, S., Schaaf-Lafontaine, N., Pereira-Martins, M., Paulus, J.-M., Fillet, G., & Beguin, Y. (2001). Administration of erythopoietin and granulocyte colony-stimulating factor in donor/recipient pairs to collect peripheral blood progenitor cells (PBPC) and red blood cell units for use in the recipient after allogeneic PBPC transplantation. Haematologica, 86 (11), 1209-18. |
Sylvestre, R.-M., Jerusalem, G., Sautois, B., Beguin, Y., & Fillet, G. (2001). Nouvelles approches thérapeutiques puor l'hypernéphrome métastasique. Médecine et Hygiène, 59, 1607-1609. |
JERUSALEM, G., & BEGUIN, Y. (June 2000). Commentary on "Positron emission tomography in lymphoma : comparison with computed tomography and Gallium-67 single photon emission computed tomography imaging". Clinical Lymphoma, 1 (1), 75-76. |
Baron, F., & Beguin, Y. (2000). Adoptive immunotherapy with donor lymphocyte infusions after allogeneic HPC transplantation. Transfusion, 40 (4), 468-76. doi:10.1046/j.1537-2995.2000.40040468.x |
Baron, F., Dresse, M.-F., & Beguin, Y. (2000). Donor lymphocyte infusion to eradicate recurrent host hematopoiesis after allogeneic BMT for sickle cell disease. Transfusion, 40 (9), 1071-3. doi:10.1046/j.1537-2995.2000.40091071.x |
Baron, F., Gothot, A., Salmon, J., Hermanne, J. P., Pierard, G., Fillet, G., & Beguin, Y. (2000). Clinical course and predictive factors for cyclosporin-induced autologous graft-versus-host disease after autologous haematopoietic stem cell transplantation. British Journal of Haematology, 111 (3), 745-53. doi:10.1046/j.1365-2141.2000.02470.x |
Frere, P., Canivet, J.-L., Gennigens, C., Rebeix, J. P., Fillet, G., & Beguin, Y. (2000). Hyperammonemia after high-dose chemotherapy and stem cell transplantation. Bone Marrow Transplantation, 26 (3), 343-5. doi:10.1038/sj.bmt.1702485 |
Herens, C., Tassin, F., Lemaire, V., Beguin, Y., Collard, E., Lampertz, S., Croisiau, C., Desouter-Lecomte, M., DE PRIJCK, B., Longree, L., & Koulischer, L. (2000). Deletion of the 5'-ABL region: a recurrent anomaly detected by fluorescence in situ hybridization in about 10% of Philadelphia-positive chronic myeloid leukaemia patients. British Journal of Haematology, 110 (1), 214-6. doi:10.1046/j.1365-2141.2000.02142.x |
Magee, L. A., von Dadelszen, P., Darley, J., & Beguin, Y. (2000). Erythropoiesis and renal transplant pregnancy. Clinical Transplantation, 14 (2), 127-35. doi:10.1034/j.1399-0012.2000.140205.x |
Roodenburg, A. J., West, C. E., Beguin, Y., Van Dijk, J. E., Van Eijk, H. G., Marx, J. J., & Beynen, A. C. (2000). Indicators of erythrocyte formation and degradation in rats with either vitamin A or iron deficiency. Journal of Nutritional Biochemistry, 11 (4), 223-30. doi:10.1016/S0955-2863(00)00070-X |
Sautois, B., Scerbo, F., Beguin, Y., & Fillet, G. (2000). Traitement des myélomes réfractaires par la Thalidomide. Médecine et Hygiène, 58, 1633-1634. |
Beguin, Y. (1999). Erythropoietin and platelet production. Haematologica, 84 (6), 541-7. |
Cazzola, M., Beguin, Y., Bergamaschi, G., Guarnone, R., Cerani, P., Barella, S., Cao, A., & Galanello, R. (1999). Soluble transferrin receptor as a potential determinant of iron loading in congenital anaemias due to ineffective erythropoiesis. British Journal of Haematology, 106 (3), 752-5. doi:10.1046/j.1365-2141.1999.01600.x |
Dresse, M.-F., Boogaerts, M., Vermylen, C., Noens, L., Ferrant, A., Schots, R., Doyen, C., Bron, D., Berneman, Z., Ferster, A., Benoit, Y., Demuynck, H., & Beguin, Y. (1999). The belgian experience in unrelated donor bone marrow transplantation: identification of center experience as an important prognostic factor. Haematologica, 84 (7), 637-42. |
Loo, M., & Beguin, Y. (1999). The effect of recombinant human erythropoietin on platelet counts is strongly modulated by the adequacy of iron supply. Blood, 93 (10), 3286-93. doi:10.1182/blood.v93.10.3286.410k29_3286_3293 |
Salmon, J., Michaux, S., Hermanne, J. P., Baudoux, E., Gerard, C., Sondag, D., Fillet, G., & Beguin, Y. (1999). Delayed massive immune hemolysis mediated by minor ABO incompatibility after allogeneic peripheral blood progenitor cell transplantation. Transfusion, 39 (8), 824-7. doi:10.1046/j.1537-2995.1999.39080824.x |
Baron, F., Hermanne, J.-P., Dowlati, A., Weber, T., Thiry, A., Fassotte, M.-F., Fillet, G., & Beguin, Y. (1998). Bronchiolitis obliterans organizing pneumonia and ulcerative colitis after allogeneic bone marrow transplantation. Bone Marrow Transplantation, 21 (9), 951-4. doi:10.1038/sj.bmt.1701198 |
Baron, F., Sadzot, B., Wang, F.-C., & Beguin, Y. (1998). Myasthenia gravis without chronic GVHD after allogeneic bone marrow transplantation. Bone Marrow Transplantation, 22 (2), 197-200. doi:10.1038/sj.bmt.1701297 |
Beguin, Y. (1998). Prediction of response to optimize outcome of treatment with erythropoietin. Seminars in Oncology, 25 (3 Suppl 7), 27-34. |
Beguin, Y., Baron, F., & Fillet, G. (1998). Influence of marrow erythropoietic activity on serum erythropoietin levels after autologous hematopoietic stem cell transplantation. Haematologica, 83 (12), 1076-81. |
Cazzola, M., Guarnone, R., Cerani, P., Centenara, E., Rovati, A., & Beguin, Y. (1998). Red blood cell precursor mass as an independent determinant of serum erythropoietin level. Blood, 91 (6), 2139-45. doi:10.1182/blood.v91.6.2139.2139_2139_2145 |
Corazza, F., Beguin, Y., Bergmann, P., Andre, M.-E., Ferster, A., Devalck, C., Fondu, P., Buyse, M., & Sariban, E. (1998). Anemia in children with cancer is associated with decreased erythropoietic activity and not with inadequate erythropoietin production. Blood, 92 (5), 1793-8. doi:10.1182/blood.v92.5.1793.417k23_1793_1798 |
Hellstrom-Lindberg, E., Ahlgren, T., Beguin, Y., Carlsson, M., Carneskog, J., Dahl, I. M., Dybedal, I., Grimfors, G., Kanter-Lewensohn, L., Linder, O., Luthman, M., Lofvenberg, E., Nilsson-Ehle, H., Samuelsson, J., Tangen, J. M., Winqvist, I., Oberg, G., Osterborg, A., & Ost, A. (1998). Treatment of anemia in myelodysplastic syndromes with granulocyte colony-stimulating factor plus erythropoietin: results from a randomized phase II study and long-term follow-up of 71 patients. Blood, 92 (1), 68-75. doi:10.1182/blood.v92.1.68.413k23_68_75 |
Pierard, G., Nikkels, N., Nikkels, A., Arrese Estrada, J., Pierard, C., Jerusalem, G., Beguin, Y., & Fillet, G. (1998). Epidermal Calprotectin Expression in Lymphocyte-Depleted Cutaneous Graft-versus-Host Reaction. Archivos Argentinos de Dermatologia, 48, 139-142. |
van Iperen, C. E., Kraaijenhagen, R. J., Biesma, D. H., Beguin, Y., Marx, J. J., & van de Wiel, A. (1998). Iron metabolism and erythropoiesis after surgery. British Journal of Surgery, 85 (1), 41-5. doi:10.1046/j.1365-2168.1998.00571.x |
Vermylen, C., Cornu, G., Ferster, A., Brichard, B., Ninane, J., Ferrant, A., Zenebergh, A., Maes, P., Dhooge, C., Benoit, Y., Beguin, Y., Dresse, M.-F., & Sariban, E. (1998). Haematopoietic stem cell transplantation for sickle cell anaemia: the first 50 patients transplanted in Belgium. Bone Marrow Transplantation, 22 (1), 1-6. doi:10.1038/sj.bmt.1701291 |
Baron, F., Deprez, M., & Beguin, Y. (1997). The veno-occlusive disease of the liver. Haematologica, 82 (6), 718-25. |
Beguin, Y., Sautois, B., Forget, P., Bury, J., & Fillet, G. (1997). Long term follow-up of patients with acute myelogenous leukemia who received the daunorubicin, vincristine, and cytosine arabinoside regimen. Cancer, 79 (7), 1351-4. doi:10.1002/(SICI)1097-0142(19970401)79:7<1351::AID-CNCR12>3.0.CO;2-Z |
Cavill, I., Macdougall, I. C., Gokal, R., Beguin, Y., Peters, T. J., Pippard, M., Schaefer, R. M., & Winearls, C. G. (1997). Iron management in patients on rHuEpo. British Journal of Renal Medicine, 2, 6-8. |
Sautois, B., Fillet, G., & Beguin, Y. (1997). Comparative cytokine production by in vitro stimulated mononucleated cells from cord blood and adult blood. Experimental Hematology, 25 (2), 103-8. |
Cazzola, M., Ponchio, L., de Benedetti, F., Ravelli, A., Rosti, V., Beguin, Y., Invernizzi, R., Barosi, G., & Martini, A. (1996). Defective iron supply for erythropoiesis and adequate endogenous erythropoietin production in the anemia associated with systemic-onset juvenile chronic arthritis. Blood, 87 (11), 4824-30. doi:10.1182/blood.v87.11.4824.bloodjournal87114824 |
Cazzola, M., Ponchio, L., Pedrotti, C., Farina, G., Cerani, P., Lucotti, C., Novella, A., Rovati, A., Bergamaschi, G., & Beguin, Y. (1996). Prediction of response to recombinant human erythropoietin (rHuEpo) in anemia of malignancy. Haematologica, 81 (5), 434-41. |
Hermanne, J.-P., TASSIN, F., Beguin, Y., & Fillet, G. (1996). Actualités thérapeutiques dans la thrombocytémie essentielle. Médecine et Hygiène, 54, 1487-1489. |
Beguin, Y. (1995). Biology and clinical uses of erythropoietin in infants and children. International Journal of Pediatric Hematology/Oncology, 2, 457-470. |
Martelli, M., Ponchio, L., Beguin, Y., Meloni, G., Mandelli, F., & Cazzola, M. (1994). Pure red cell aplasia following peripheral stem cell transplantation: complete response to a short course of high-dose recombinant human erythropoietin. Haematologica, 79 (5), 456-9. |
Beguin, Y., Clemons, G. K., Pootrakul, P., & Fillet, G. (1993). Quantitative assessment of erythropoiesis and functional classification of anemia based on measurements of serum transferrin receptor and erythropoietin. Blood, 81 (4), 1067-76. doi:10.1182/blood.v81.4.1067.1067 |
Feron, C., Gothot, A., Grosdent, J.-C., Van Cauwenberge, J.-R., Schaaps, J.-P., Beguin, Y., & Paulus, J.-M. (1993). Purification, expansion, and multiple fluorochrome labeling of cord blood hemopoietic precursors: preliminary results. Journal of Hematotherapy, 2 (2), 259-61. doi:10.1089/scd.1.1993.2.259 |
Cazzola, M., Ponchio, L., Beguin, Y., Rosti, V., Bergamaschi, G., Liberato, N. L., Fregoni, V., Nalli, G., Barosi, G., & Ascari, E. (1992). Subcutaneous erythropoietin for treatment of refractory anemia in hematologic disorders. Results of a phase I/II clinical trial. Blood, 79 (1), 29-37. doi:10.1182/blood.v79.1.29.bloodjournal79129 |
Beguin, Y., Clemons, G. K., Oris, R., & Fillet, G. (1991). Circulating erythropoietin levels after bone marrow transplantation: inappropriate response to anemia in allogeneic transplants. Blood, 77 (4), 868-73. doi:10.1182/blood.v77.4.868.bloodjournal774868 |
Beguin, Y., Lipscei, G., Thoumsin, H., & Fillet, G. (1991). Blunted erythropoietin production and decreased erythropoiesis in early pregnancy. Blood, 78 (1), 89-93. doi:10.1182/blood.v78.1.89.89 |
Beguin, Y., Loo, M., & Fillet, G. (1991). Le dosage du récepteur circulant de la transferringe : une nouveauté pour quantifier l'érythropoïèse. Médecine et Hygiène, 49, 2041-2045. |
Beguin, Y., Sautois, B., & Fillet, G. (1991). Perspectives diagnostiques et thérapeutiques de l'érythropoïétine. Médecine et Hygiène, 49, 2034-2045. |
Andrien, F., Fassotte, M.-F., Beguin, Y., & Fillet, G. (1990). Traitement des lymphomes non hodgkiniens : de l'abstention thérapeutique à la greffe de moelle. Médecine et Hygiène, 48, 3672-3676. |
Beguin, Y., Bours, V., Delbrouck, J.-M., Robaye, G., Roelandts, I., & Fillet, G. (1990). Relationship of serum selenium to tumor activity in acute non lymphocytic leukemia (ANLL) and chronic lymohocytic leukemia (CLL). Metal ions in Biology and Medecine, 500-502. |
Beguin, Y., Bours, V., Delbrouck, J.-M., Robaye, G., Roelandts, I., Fillet, G., & Weber, G. (1990). Use of PIXE to measure serum copper, zinc, selenium, and bromine in patients with hematologic malignancies. Nuclear Instruments and Methods in Physics Research. Section B, Beam Interactions with Materials and Atoms, B49, 202-204. doi:10.1016/0168-583X(90)90243-N |
Fassotte, M.-F., Beguin, Y., Andrien, F., & Fillet, G. (1990). Allogreffes et autogreffes de moelle osseuse. Indications, résultats, perspectives. Médecine et Hygiène, 48, 3666-3671. |
Fillet, G., Baldelli, L., & BEGUIN, Y. (1989). Model of reticuloendothelial iron metabolism in humans: abnormal behavior in idiopathic hemochromatosis and in inflammation. Blood, 74 (2), 844-51. doi:10.1182/blood.v74.2.844.bloodjournal742844 |
Beguin, Y., Delbrouck, J.-M., Robaye, G., Roelandts, I., Bury, J., Fillet, G., & Weber, G. (1987). Correlation of serum trace elements with other biological parameters in hemoproliferative disorders. Trace element analytical chemistry in medicine and biology, 4, 537-545. |
Andrien, F., Lemaire, M., Beguin, Y., Bury, J., Closon, J., David, J.-L., Dejardin-Closon, M.-T., Duvivier, A., Fillet, G., & Tjean, M. (1986). Second tumors and myeloproliferative diseases after Hodgkin's disease treatment. Leukemia Research, 10, 887. |
Burniat, A., Noël, A., Colige, A., Vanderplasschen, A., de Kerchove d'Exaerde, A., Kupper Cardozo, A., Van Keymeulen, A., Moens, A., Bondue, A., Herpain, A., Marchant, A., Loumaye, A., Beck, B., Van den Heyden, B., Corvilain, B., Lakaye, B., Rogister, B., Malgrange, B., Michiels, C., ... Brunko, E. (2023). Cent scientifiques répliquent à SEA (Suppression des Expériences sur l’Animal vivant) et dénoncent sa désinformation. La Libre Belgique. |
Baron, F., & Beguin, Y. (2010). GVHD chronique et effet anti-tumoral. Correspondance en Onco-Hématologie, 5, 12-16. |
Dresse, M.-F., & Beguin, Y. (2007). Haematopoietic stem cell transplantation for children in Belgium. Tijdschrift van de Belgische Kinderarts, 1, 44-51. |
Beguin, Y., Loo, M., R'Zik, S., Sautois, B., & Fillet, G. (1994). Significance of soluble transferrin receptor. Molecular Biology of Hematopoiesis, 451-464. |
Beguin, Y., & Fillet, G. (1991). Erythropoïétine : utilisation diagnostique et thérapeutique. Revue de l'Association Belge des Technologues de Laboratoire, 18 (3), 161-168. |
VANDERMEULEN, M., Mohamed Wais, M., DELBOUILLE, M.-H., MAGGIPINTO, G., BEGUIN, Y., & DETRY, O. (August 2021). Long term follow-up of liver transplant recipients after allogeneic mesenchymal stromal cell infusion. Transplant International, 34 (S1 OP282), 45. |
VANDERMEULEN, M., MAGGIPINTO, G., JOURET, F., BEGUIN, Y., & DETRY, O. (September 2017). DO MESENCHYMAL STROMAL CELLS PROMOTE HLA SPECIFIC ANTIBODIES FORMATION AFTER INFUSION IN LIVER TRANSPLANT RECIPIENTS? Transplant International, 30 (S2), 548 (PLB051. |
DETRY, O., VANDERMEULEN, M., DELBOUILLE, M.-H., SOMJA, J., BLETARD, N., BRIQUET, A., LECHANTEUR, C., GIET, O., BAUDOUX, E., Hannon, M., Baron, F., & BEGUIN, Y. (January 2017). UNE INJECTION UNIQUE DE CELLULES STROMALES MESENCHYMATEUSES AU JOUR 3 APRES GREFFE HEPATIQUE EST INSUFFISANTE POUR INDUIRE UNE TOLERANCE OPERATIONNELLE. Transplant International, 30 (suppl 1), 8 (O12. |
Heusschen, R., Muller, J., Binsfeld, M., Marty, C., Plougonven, E., DUBOIS, S., Mahli, N., Moermans, K., Carmeliet, G., Léonard, A., BARON, F., Cohen-Solal, M., Vanderkerken, K., BEGUIN, Y., Menu, E., & CAERS, J. (2016). SRC kinase inhibition with saracatinib limits the development of osteolytic bone disease in multiple myeloma. Belgian Journal of Hematology. |
WEEKERS, L., Erpicum, P., DETRY, O., BONVOISIN, C., BRIQUET, A., LECHANTEUR, C., BAUDOUX, E., JOURET, F., & BEGUIN, Y. (2016). administration of Third-Party Mesenchymal Stromal Cells at the Time of Kidney Transplantation: Interim Safety Analysis at One-Year Follow-Up. Transplant International, 29 (Suppl 2), 13 -p6. |
Sid, S., LUTTERI, L., BEGUIN, Y., Louis, E., Beckers, A., & VALDES SOCIN, H. G. (2015). Familial thyrogastric autoimmune syndrome : a study of 22 kindreds. In Abstract book - 20th Annual Congress of the Belgian Society of Internal Medicine. |
DETRY, O., VANDERMEULEN, M., DELBOUILLE, M.-H., DE ROOVER, A., SOMJA, J., BLETARD, N., BRIQUET, A., LECHANTEUR, C., HONORE, P., & BEGUIN, Y. (November 2015). Infusion of third-party mesenchymal stem cells after liver transplantation: a phase-1, open-label, clinical study. Transplant International, 28 (S4), 10/O27. |
WEEKERS, L., ERPICUM, P., DETRY, O., JOURET, F., LECHANTEUR, C., DELBOUILLE, M.-H., BRIQUET, A., BAUDOUX, E., & BEGUIN, Y. (November 2015). Third-party mesenchymal stem cell infusion in kidney transplant recipient: 6-month safety interim analysis. Transplant International, 28 (S4), 223-224/BO278. |
WEEKERS, L., ERPICUM, P., DETRY, O., LECHANTEUR, C., BAUDOUX, E., JOURET, F., & BEGUIN, Y. (May 2015). Third-party mesenchymal stem cell infusion in kidney transplant recipient: 6-month safety interim analysis. American Journal of Transplantation, 15 (suppl 3). |
DETRY, O., VANDERMEULEN, M., DELBOUILLE, M.-H., DE ROOVER, A., SOMJA, J., BLETARD, N., BRIQUET, A., LECHANTEUR, C., & BEGUIN, Y. (April 2015). Infusion of third-party mesenchymal stromal cells after liver transplantation: a phase 1, open-label, clinical study. Journal of Hepatology, 62 (S2), 311 (P0052. |
DETRY, O., VANDERMEULEN, M., DELBOUILLE, M.-H., DE ROOVER, A., SOMJA, J., BLETARD, N., BRIQUET, A., LECHANTEUR, C., & BEGUIN, Y. (March 2015). Infusion of third-party mesenchymal stream cells after liver transplantation: a phase-1, open-label, clinical study. Acta Gastro-Enterologica Belgica, 78 (1), 29. |
FOGUENNE, J., SIMUL, M., KEUTGENS, A., TASSIN, F., Bonnet, C., BEGUIN, Y., JAMAR, M., LAMBERT, F., & GOTHOT, A. (2015). Multiparameter flow cytometric analysis of composite lymphoma: case report of a mantle cell lymphoma associated with a B-cell chronic lymphocytic leukemia and an aberrant T cell subset. Belgian Journal of Hematology. |
Heusschen, R., Muller, J., Binsfeld, M., Plougonven, E., Mahli, N., Carmeliet, G., Léonard, A., Cohen-Solal, M., Vanderkerken, K., BEGUIN, Y., Menu, E., & CAERS, J. (2015). The SRC inhibitor AZD0530 prevents the development of osteolytic bone disease in multiple myeloma. Blood. |
Heusschen, R., Muller, J., Binsfeld, M., Plougonven, E., Mahli, N., Carmeliet, G., Léonard, A., Cohen-Solal, M., Vanderkerken, K., BEGUIN, Y., Menu, E., & CAERS, J. (2015). The SRC inhibitor AZD0530 prevents the development of osteolytic bone disease in multiple myeloma. Blood, 126 (23), 3018. |
Muller, J., Binsfeld, M., DUBOIS, S., Carmeliet, G., Beguin, Y., Heusschen, R., & CAERS, J. (2015). The anti-angiogenic peptide Anginex blocks osteoclastogenesis. Belgian Journal of Hematology, Abstracts book. |
BEGUIN, Y., ZACHEE, P., MAERTENS, J., KERRE, T., ORY, A., SEIDEL, L., GRAUX, C., LEWALLE, P., VAN GELDER, M., THEUNISSEN, K., WILLEMS, E., EMONDS, M.-P., DE BECKER, A., & BARON, F. (December 2014). Nonmyeloablative allogeneic hematopoietic cell transplantation following Fludarabine Plus 2 Gy TBI or ATG Plus 8 Gy TLI: a phase II randomized study from the Belgian Hematological Society. Blood, 124 (21), 542. |
JASPERS, A., BARON, F., MAERTENS, J., DE PRIJCK, B., SCHOTS, H., BONNET, C., HAFRAOUI, K., WILLEMS, E., SERVAIS, S., FILLET, G., & BEGUIN, Y. (December 2014). Long-term safety follow-up of a rendomized trial of Darbepoetin Alpha and intravenous iron following autologous hematopoietic cell transplantation. Blood, 124 (21), 3948. |
Binsfeld, M., BEGUIN, Y., Belle, L., Otjacques, E., HANNON, M., BRIQUET, A., Drion, P., Bogen, B., Baron, F., & CAERS, J. (2014). Establishment of a murine graft-versus-myeloma model using allogeneic stem cell transplantation. Belgian Journal of Hematology. |
Binsfeld, M., Heusschen, R., Lamour, V., Van Valckenborgh, E., Bellahcene, A., Baron, F., BEGUIN, Y., & CAERS, J. (2014). Multiple myeloma cells instruct myeloid-derived suppressor cells to release pro-angiogenic cytokines. Belgian Journal of Hematology. |
Heusschen, R., Schulkens, I., Muller, J., Griffoen, A., Beguin, Y., Thijssen, V., & CAERS, J. (2014). Galectins in cancer: jacks of all trades. International Journal of Molecular Medicine. |
JASPERS, A., Baron, F., WILLEMS, E., HAFRAOUI, K., Bonnet, C., & Beguin, Y. (2014). Long-term survival in patients receiving rhEPO following allogeneic hematopoietic cell transplantation. Belgian Journal of Hematology, 14. |
Muller, J., CAERS, J., Binsfeld, M., Dubois, S., Carmeliet, G., BEGUIN, Y., & Heusschen, R. (2014). Galectin expression in the multiple myeloma microenvironment. Belgian Journal of Hematology. |
SID, S., Dugauquier, D., DE PRIJCK, B., Bonnet, C., & Beguin, Y. (2014). Hemolytic crisis induced by rasburicase administration revealing G-6-PD deficiency. Belgian Journal of Hematology, 17-18. |
Belle, L., Binsfeld, M., HANNON, M., CAERS, J., BRIQUET, A., MENTEN, C., BEGUIN, Y., Humblet-Baron, S., & Baron, F. (2013). Combination of Regulatory T Cells Injection with Rapamycin for Treatment of Chronic Graft-versus-Host Disease. Belgian Journal of Hematology. |
Binsfeld, M., Otjacques, E., Hannon, M., DUBOIS, S., Beguin, Y., Baron, F., & CAERS, J. (2013). The Immunomodulating Peptide Thymosin Alpha 1 Has no Effect on Multiple Myeloma Evolution and on Immune Reconstitution. Belgian Journal of Hematology, Abstracts book (Supplement of 28th General Meeting of the Belgian Hematological Society), 41. |
Hannon, M., Humblet-Baron, S., Graux, C., Maertens, J., Kerre, T., Theunissen, K., Daulne, C., Willems, E., Belle, L., Binsfeld, M., Gothot, A., Beguin, Y., & Baron, F. (2013). Comparison of Immune Reconstitution after Hematopoietic Stem Cell Transplantation with Flu-TBI versus TLI-ATG Conditioning. Belgian Journal of Hematology, Abstracts book (Supplement of 28th General Meeting of the Belgian Hematological Society), 38. |
Hannon, M., LECHANTEUR, C., Somja, J., Lucas, S., Belle, L., Bruck, F., Baudoux, E., Beguin, Y., Humblet-Baron, S., & Baron, F. (2013). Infusion of CliniMACS (Myltenyi Biotec) Enriched Regulatory T Cells Delays Experimental Xenogeneic Graft-versus-Host Disease. Belgian Journal of Hematology, Abstracts book (Supplement of 28th General Meeting of the Belgian Hematological Society), 15. |
JASPERS, A., Baron, F., WILLEMS, E., HAFRAOUI, K., Vanstraelen, G., Bonnet, C., & Beguin, Y. (2013). Erythropoietin therapy after allogeneic hematopoietic cell transplantation : a prospective randomised trial. Belgian Journal of Hematology, 16. |
SERVAIS, S., Hannon, M., Daulne, C., Gothot, A., Beguin, Y., & Baron, F. (February 2012). Longitudinal Monitoring of Immune Reconstitution after Allogeneic Peripheral Blood Stem Cell Transplantation (PBSCT): Impact of T-Cell Depletion of the Graft. Biology of Blood and Marrow Transplantation, 18 (2), 274-S275. doi:10.1016/j.bbmt.2011.12.193 |
Binsfeld, M., Belle, L., Hannon, M., DUBOIS, S., Otjacques, E., Beguin, Y., Baron, F., & CAERS, J. (2012). Adaptation of a Murine Chronic GVH Model to Study Graft versus Myeloma Effect after Allogeneic Transplantation. Belgian Journal of Hematology, Abstracts book (Supplement of 27th General Meeting of the Belgian Hematological Society), 16. |
Binsfeld, M., Belle, L., Hannon, M., Hofgaard, Dubois, S., Otjacques, E., BEGUIN, Y., Bogen, BARON, F., & CAERS, J. (2012). Adaptation of a murine chronic GvH model to study graftversus- myeloma effect after allogeneic transplantation. Bone Marrow Transplantation, 47 (Suppl.1). |
Hannon, M., Humblet-Baron, S., Graux, C., Maertens, J., Kerre, T., Theunissen, K., Daulne, C., Willems, E., Belle, L., Binsfeld, M., Gothot, A., Beguin, Y., & Baron, F. (2012). Comparison of Immune Reconstitution after Hematopoietic Stem Cell Transplantation with Flu-TBI versus TLI-ATG Conditioning. Haematologica, 97 (Supplement 1), 180. |
MENTEN, C., Castermans, E., Hannon, M., Ormenese, S., Beguin, Y., & Baron, F. (2012). What is the Contribution of Host-Derived CMV Immunity after Allogeneic Transplantation following Non-Myeloablative Conditioning? Haematologica, 97 (Supplement 1), 720. |
MENTEN, C., Castermans, E., Hannon, M., Ormenese, S., Beguin, Y., & Baron, F. (2012). Evidence for Expansion of Host-derived CMV-specific CD8+ T cells after Allogeneic Transplantation with Non-Myeloablative Conditioning. Belgian Journal of Hematology, Abstracts book (Supplement of 27th General Meeting of the Belgian Hematological Society), 16. |
Hannon, M., Humblet-Baron, S., Graux, C., Maertens, J., Kerre, T., Daulne, C., Willems, E., Gothot, A., Beguin, Y., & Baron, F. (2011). Comparison of Immune Reconstitution after Non-myeloablative Hematopoietic Cell Transplantation (HCT) with Flu-TBI versus TLI-ATG Conditioning. Belgian Journal of Hematology, Abstracts book (Supplement of 26th General Meeting of the Belgian Hematological Society), 8. |
SERVAIS, S., Hannon, M., Daulne, C., Gothot, A., Beguin, Y., & Baron, F. (2011). Longitudinal Monitoring of Immune Reconstitution After Allogeneic Peripheral Blood Stem Cell Transplantation (HSCT): Impact of T Cell Depletion of the Graft. Belgian Journal of Hematology, Abstracts book (Supplement of 26th General Meeting of the Belgian Hematological Society), 31. |
Humblet-Baron, S., CASTERMANS, E., Vanbellinghen, J.-F., Hannon, M., Jacobs, N., WILLEMS, E., Ormenese, S., Beguin, Y., & Baron, F. (February 2009). What Is The Role For Regulatory T-Cells After Nonmyeloablative Conditioning? Biology of Blood and Marrow Transplantation, 15 (2), 122-123. doi:10.1016/j.bbmt.2008.12.377 |
Briquet, A., Dolhet, M., Beguin, Y., & Gothot, A. (2009). Inhibition of the Jagged-1/Notch pathway increases the hematopoiesis-supportive activity of mesenchymal stem cells. Experimental Hematology, 37 (9), 77. |
Castermans, E., Hannon, M., Cheynier, R., Seidel, L., Humblet-Baron, S., WILLEMS, E., Corbier, S., Gothot, A., Geenen, V., Sandmaier, B. M., Storb, R. F., Beguin, Y., & Baron, F. (2009). Thymic Recovery After Allogeneic Hematopoietic Cell Transplantation with Nonmyeloablative Conditioning Might Be Limited to Patients Younger Than 60 Years of Age. Blood, 114 (22), 1149. |
Humblet-Baron, S., CASTERMANS, E., Vanbellighen, J.-F., Hannon, M., Jacobs, N., Beguin, Y., & Baron, F. (February 2008). What is the Role for Regulatory T-Cells after Nonmyeloablative conditioning. Biology of Blood and Marrow Transplantation, 14 (2), 136-137. doi:10.1016/j.bbmt.2007.12.383 |
Briquet, A., Dolhet, M., Demeuse, J., BEGUIN, Y., & GOTHOT, A. (August 2007). Study of contribution of signalling pathways Notch, Wnt, Shh and BMP in mesenchymal stem cell prohaematopoietic activity. Acta Clinica Belgica, 62 (4), 256. |
WILLEMS, E., CASTERMANS, E., Baron, F., BAUDOUX, E., Wanten, N., Bonnet, C., HAFRAOUI, K., Frère, P., Fillet, G., & Beguin, Y. (2005). Nonmyeloablative stem cell transplantation with CD8-depleted or unmanipulated peripheral blood stem cells: a prospective randomized trial. Blood, 106 (1075). |
Bovy, C., Beguin, Y., Gothot, A., Rorive, G., & Krzesinski, J.-M. (2003). Hypochromic mature erythrocytes: a specific marker of iron deficiency. Acta Clinica Belgica, 58-3 (4), 325. |
Bovy, C., Beguin, Y., Gothot, A., Rorive, G., & Krzesinski, J.-M. (2003). Follow-up of iron microalbuminuria in hypertensive patients: a belgian promise survey. Acta Clinica Belgica, 58-3 (4), 328. |
Beguin, C., Kwan, O., Ritacco, C., Debray, J.-C., Dejardin, E., Dubois, S., Köse, M. C., Canti, L., Courtois, J., Seidel, L., Daulne, C., Caers, J., Beguin, Y., Ehx, G., & Baron, F. (17 November 2023). TNF-α priming of human regulatory T cells does not increase their ability to prevent xenogeneic graft-versus-host disease [Paper presentation]. Congrès annuel de la Société Francophone de Greffe de Moelle et Thérapie Cellulaire, Lille, France. |
Bodart, G., THYS, M., GANGOLF, M., CUNIN, M.-P., LAMBERT, F., POUSTOVOITOV, A., Beguin, Y., Kolh, P., & Jacques, J. (2022). Développement d’un outil de pilotage des patients oncologiques au CHU de Liège [Paper presentation]. Giseh 2022, Saint-Etienne, France. |